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ABSTRACT
The problem of occupational allergy has only been highlighted 
in recent years. Diseases and disorders arising from acute 
exposure to large quantities of chemicals and concern over 
their potential toxic properties generally overshadow 
considerations of likely allergic reactions and the possibility 
of sensitisation developing. This thesis summarises the basic 
mechanisms of immunity and allergy and lists the substances 
which have given rise to sensitisation and allergic reactions 
in workers exposed to them. The literature covering allergy 
and sensitisation (including case histories of workers, 
animal studies and laboratory investigations) to particular 
organic chemicals encountered in occupational environments 
is reviewed. The mechanisms by which these chemicals stimulate 
allergic reactions in the body are discussed with particular 
reference to the chemical structure and molecular 
configuration of the chemicals. Basic physical data, structural 
formulae, the adverse reactions reported and related details 
are tabulated for each chemical. Occupational allergy to 
acid anhydrides is considered in more detail and typical 
case histories of sensitised workers given. The question 
of sensitisation generally is discussed. Recommendations 
for control measures to prevent or alleviate cases of 
occupational allergy, on improvements in the screening of 
workers and for the wider availability of information on 
the subject are made. Tests used in allergy investigations 
are summarised and a glossary of medical and related terms 
is given.
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)INTRODUCTION
The presence of diseases and disorders in workers developing
from and specifically related to their occupations has
been recognised for centuries. As early as Roman times
there was some awareness of the connection between
occupations and diseases particularly in relation to
metal miners and sulphur workers. In the seventeenth 
1
century Paracelsus a physician, identified the miner's
liability to lung disorders and the smelter's risk of
poisoning by heavy metals. Ramazzini, the father of
2
occupational medicine, published a treatise in 1700 and 
not only identified many occupational disorders but also 
suggested ways of avoiding or reducing them. Knowledge 
and awareness of conditions related to particular trades 
or industries has continued steadily up to the present.
However, the potential for exposure to hazardous chemicals 
today is greater than ever before, not only in the 
working environment but also in the home and during 
recreational and other leisure activities. In the present 
century, and especially since the Second World War, 
the rapid development and diversity of industry have created 
a marked increase in the numbers of organic and inorganic 
substances that are toxic or have potential as allergens 
or irritants.
Recent literature on incidents of occupational allergy and 
information regarding case histories is fragmented and 
of variable quality. Statistics on the prevalence 
of particular conditions are difficult to obtain with 
any degree of accuracy. One reason for this is that unlike 
many other occupational diseases,allergy per se is not a 
notifiable condition under current health and safety 
legislation in this country.
The subject of sensitisation and occupational asthma
was reviewed by the Industrial Injuries Advisory Council
in 1981 when seven groups of agents were studied. Principally
4
as a result of the Councils report occupational asthma was 
scheduled in March 1982 as a prescribed disease enabling 
workers suffering from permanent disablement caused by 
certain agents to claim industrial benefit. Whilst only 
seven groups of agents are currently listed (see table l) 
it is likely that further agents will be added in due 
course. Benefit is only available to workers suffering 
an irreversible condition and is not claimable in 
respect of short term disability. Accordingly only serious 
cases of the disease are reported and then only in 
retrospect. Furthermore occupational asthma can develop 
from non-allergic causes, especially through irritation, 
and it is such cases which are likely to be permanently 
disabling and therefore reported rather than those 
developing through allergy.
TABLE 1
OCCUPATIONAL ASTHMA
5
Prescribed causal agents under the Industrial Injuries Scheme
Isocyanates •
Platinum salts
Acid anhydride and amine hardening agents (used in 
epoxy resin systems)
Fumes arising from use of rosin as soldering flux 
Proteolytic enzymes
Dusts arising from barley, oats, rye, wheat or maize or 
meal or flour made from such grain 
Animals or insects (used in research, education and 
laboratories etc)
)
)The Industrial Injuries Advisory Council is currently 
■ 6
reviewing the data on other known sensitisers with a
view to extending the list of prescribed causal agents
for which injury benefit can be claimed by chronic sufferers.
Much of the published data on occupational allergy
(and respiratory allergy in particular) is derived from
case histories of individual workers referred to specialists
for diagnosis and treatment. Some surveys and epidemiological
studies of groups of workers and whole industrial plants
have been undertaken. A variety of study options have 
7
been used including both cross sectional and longitudinal, 
retrospective, prospective and specific groupings. (See 
figure l). Limited studies on animals particularly the guinea pig 
have also been undertaken. In many cases strong immunological 
evidencecf an allergic mechanism causing symptoms in workers 
suffering adverse reactions to substances at work has 
been obtained but in others an allergic involvement can 
only be deduced or suspected. Clearly this reduces the 
reliability of the data when taken out of context.
The manner in which the respiratory sensitisation problem 
has surfaced in different occupations has varied considerably. 
Farmer’s lung. Malt worker's lung and allergies in workers 
handling animals have been recognised for some time. The 
causal agents are known to be proteins or other macro- 
molecules present in moulds and other fungi growing on 
bay or barley and in the latter case, arising from animal 
waste products (dander).
FIGURE 1
STUDY OPTIONS IN OCCUPATIONAL EPIDEMIOLOGY .
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Traditionally emphasis has been given to diseases and 
disorders (eg. asphyxia, bums, poisoning etc.) resulting 
from acute exposure to fairly high concentrations of such 
substances and the physical problems (eg. fire and 
explosion risk) presented by them. More recently concern 
has been directed towards more long term conditions 
(including asthma and various forms of cancer) likely 
to be caused by continued exposure to lower concentrations. 
Indeed routine toxicity testing involving animals has 
become established practice and is mandatory in certain 
cases.
The problem of occupational allergy however, remains 
relatively obscure and masked to a large extent by 
these ’more important’ considerations. The limitations of 
current data, inability to establish unequivocal diagnosis 
in apparently sensitised patients, the low concentrations 
of chemicals involved and the small numbers of workers 
likely to be affected often mean that little priority 
is given to this subject in many industries. The lack of 
established aniiflal tests to screen chemicals for the 
existence of sensitising effects on humans together with 
problems of identifying highly susceptible workers 
prior to exposure are additional factors. Dermatitis (which 
may be allergy related in some cases) is somewhat of an 
exception with positive steps being taken in most factories 
to eliminate or reduce incidents amongst exposed workers, 
although such precautions are often introduced for different 
reasons and prevention of dermatitis is a secondary 
consideration.
)One of the first instances in industry was the sensitisation 
of workers involved in enzyme detergent manufacture
which was also linked with skin problems amongst workers
. ■ 8 
and consumers using these products. Most recent attention
has focused on a wide range of organic isocyanate materials
used in industry. In the printing and packaging trades
where isocyanate containing inks and adhesives have been
widely used trade union pressure has led to substitution
of many of these products, currently similar concern is
being expressed over the use of isocyanates in the production
of polyurethane foam and the spraying of polyurethane paints
Allergy to inorganic compounds particularly platinum salts
is also well established with 20—25^ of the workforce in
9
one plant alone known to suffer from the condition.
Workers in the pharmaceutical and animal feed industries 
are also high on the list of occupational allergy sufferers.
This dissertation is primarily concerned with respiratory 
allergies and other adverse reactions in man arising from 
substances released into the environment in industrial 
(and other occupational) processes focussing in particular 
on the molecular basis of such reactions. The substances 
concerned are principally reactive organic chemicals
of relatively low molecular weight present in dusts, gases
and vapours in working environments as a consequence of
particular industrial or related processes. The adverse
administered for therapeutic purposes 
effects of inorganic chemicals, drugs/and of living
organisms have been specifically excluded from this study.
)IMITOITY AND ALLERGY
2.1 Native and adaptive immunity
Immunity refers to the capacity enjoyed by an organism 
to remain unaffected by harmful agents in its environment 
and from those arising from within itself. The defence 
mechanisms responsible for this immunity are understandably 
complex and varied but two broad classifications are 
recognised:
a) Non-specific or native immunity - general 
body defences which kill or prevent the 
multiplication of micro-organisms or other 
parasites.
b) Specific or adaptive immunity - mechanisms 
that are activated individually after a 
microbe or other foreign material invades 
the body.
Native immunity is provided by several routes including
the physical barriers of the skin and membranes and the
filtering of nasal passages. Bacteriod.dal enzymes in saliva,
acidic substances in the stomach and chemical agents in the
blood (eg properdin) and other tissue fluids capable of
equally
inhibiting or destroying microorganisms are all/important. In 
addition all higher animals contain scavenging cells which 
ingest and destroy foreign particles. These are principally 
of two types, namely macrophages and granulocytes 
(polymorphonuclear leucocytes) both of which originate 
from cells in the bone marrow.
)Granulocytes are highly motile cells containing granules 
(packets of powerful digestive enzymes and bactericidal 
agents) and are attracted by chemotactic agents and migrate 
to foreign material including bacteria which they ingest 
and digest. Macrophages also efficiently ingest foreign 
particles and digest bacteria but are slower moving than 
granulocytes.
A third type of cell(Eosinophils) which also originate 
from the bone marrow, have a phagocytic potential although 
their function is largely unknown. They accumulate at 
sites of antigen-antibody reaction in response to specific 
chemotactic factors liberated locally. Immune reactions
■ V 10 -
involving IgE are particularly prone to attract eosinophils.
They are also implicated in the processing and cell to
cell transfer of antigen breakdown products. In parasitic
the number of
infections an increase in/blood eosinophils usually occurs#
A fundamental property of adaptive immunity is a highly 
specific memory, since the system actually l e a m s  f rom first 
interaction with a given agent. Furthermore the system 
has the ability to recognise materials that are foreign 
ie. to distinguish self from non-self. A remarkable and 
economical feature of the immune system is that recognition 
leads by one or more processes to inactivation.
Materials which can give rise to specific immune 
responses and interact with the cells and/or antibodies 
produced are termed antigens. Some foreign materials 
(generally of low molecular weight) are able to interact
10
specifically with pre -existing cells and/or antibodies 
but require to be conjugated with another material, usually 
protein, before being able to elicit a specific immune 
response themselves - these are known as haptens. In these 
cases it is the chemical reactivity of the molecule which 
is important not its size.
Recognition of a material as self occurs as a result of 
the material being present (at a suitable concentration) 
during the prenatal development of the organism. Additionally 
for material to be regarded as self it must be accessible 
to the cells of the immune system during development.
The immune system of an organism will generally not respond 
against material regarded as self. This self-tolerance 
is achieved, during foetal development, by the removal or 
inactivation of certain cells of the immune system capable of 
reacting against the antigens of the body.
Tolerance to foreign antigens can also be achieved after 
birth through the administration of very small amounts 
of antigen repeatedly over a period of weeks or the 
administration of large amounts over a shorter period of 
time. The given antigen must be present in a form which 
allows it to persist in the circulation and not all be 
taken up by macrophages and related processes. The 
maintenance of tolerance must be a continuous process 
since the active principle's of specific immunity are 
constantly changing and new cells and/or antibodies reactive 
to the given tolerated antigen may evolve which would initiate 
an immune response against it unless they are inactivated.
11
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Most antigens have several distinct areas on their surfaces 
which are recognised as foreign and give rise to the 
specific responses against them, these areas are known as 
antigenic determinants. When two different antigens have 
one common antigenic determinant some of the antibody 
response made against one antigen will be able to react 
with the other, such antigens are known as cross-reacting 
antigens.
2.2 The Immune System and Specific Immunity 
The immune response in specific immunity centres around 
a family of white blood cells called lymphocytes. In adult 
animals lymphocytes are derived from stem cells which are 
continuously formed in the bone marrow; these stem cells 
pass in the bloodstream from the bone marrow to specialist 
tissues known as lymphoid organs, eg. the thymus gland, 
spleen, tonsils, appendix, lymphnodes etc. The life 
cycle and behaviour of lymphocytes depends upon the location 
of the stem cells from which they originate, ie. whether 
they migrate from the bone marrow into the thymus gland 
or into other lymphoid tissues. Although all lymphocytes 
are similar in appearance they acquire characteristic 
components in surface membranes and differences in behaviour 
depending on the lymphoid tissues to which they relate.
(See figure 2.)
The immune system can be regarded as two parts, humoral 
(antibody mediated) immunity and cell-mediated immunity, 
although there is interaction between the two systems 
in various immune responses. The two arms of the immune
FIGURE 2
DIFFERSÎTriATION OF LYMPHOCYTES
11
A SCHEMATIC DIAGRAM OF THE FOEAATION OF LYI4PH0CYTES FROM 
BONE MARROW STH-1 CELLS AND THEIR DIFFEREITTIATION INTO VARIOUS 
TYPES OF CELL HiVOLVED IN THE IMMUIÎE RESPONSE.
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system were discovered through experiments which tested: '
i) whether a particular sort of immune response 
occurring in an individual could he transferred 
to a previously un immunised individual hy serum 
taken from the former and separated from his 
hlood cells,
or ii) whether the reactivity could he transferred 
hy the cells in the absence of serum.
Such experiments have made it possible to characterise mary 
features of the two arms of the adaptive immune response 
in isolation from each other.
2.5 Antibodies
Humoral immunity is the arm based on soluble serum factors. 
Although there are many different reactivities in this 
category they have one prime feature in common - their 
specificity for particular foreign materials is dependant 
on specific antibody. For this reason reactivities within 
this area are termed antibody-directed immunity. Humoral 
antibody, namely the four principal types of immunoglbbuL ins 
(referred to as IgA, IgE, IgG and I ^ )  are manufactured 
by cells of the B-cell system. (igD is also produced but 
its role is not understood.) (See figure 5).
The clonal selection theory of antibody formation (See figure 
4) was developed in the 1950’s by Burnet based on the 
selective hypothesis of Jeme. Circulating small B-lymphocytes 
carry highly specific receptors on their surface. Antigen 
selects from this preexisting array of cells and those
14
FIGURE 3
THE STRUCTURE OF IMMUNOGLOBULINS - THE ANTIBODY MOLECULE
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LOOPS (d o m a i n s ) i n t h e p r o t e i n b a c k b o n e
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FIGURE 4.
ANTIBODY PRODUCTION - THE CLONAL SELECTION THEORY
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having specific receptors to it are stimulated to divide 
and produce a clone of daughter cells. Some of these 
progeny are memory cells whilst others develop and mature 
into plasma cells, which have a particular ability to 
produce antibody at a high rate. The presence of memory 
cells enables a subsequent challenge with the same antigen 
to invoke a greater response than the previous encounter.
The commonest type of immunoglobulin (igC) is distributed
throughout the body in both the blood and tissue fluids 
X certain sub-classes areJ a n d /  able to cross the placenta, thereby conferring
immunity on the foetus.IgG- is capable of activating 
complement and oR initiating complement fixation (see below). 
I ^ ,  a much larger molecule than IgG is found principally 
intravascular and is able to achieve greater Complement 
activation than IgG. IgA is the principal immunoglobulin 
found in tears, milk, sweat, saliva and mucous secretions.
It is found in the lining of the respiratory tract and 
the gut where it is capable of surviving hydrolytic conditions 
\ for significant periods. The fourth main type, (igE) often
referred to as reaginic antibody, is involved in immediate 
type allergic reactions. It has the ability to bind to
13
the surface of mast cells and induce the release of 
histamine and other pharmacologic mediators from these 
cells following antigen binding.
Antibody can affect antigen in three ways (See figure 5)*”
a) Direct binding of the antigen by antibody 
( especially where the antigen is a virus or 
bacterial toxin) neutralises it and interferes
17
)
with its proliferation, movement and ability 
to attack other cells in the body- a process 
known as agglutination df the antigen is particulate
b) Binding of antibody to antigen in the presence 
of complement (see later) enhances the lysis
of cellular antigen and also facilitates phago­
cytosis by scavenging cells.
c) By directing and influencing the activity of 
certain cells in association with the binding 
of antibody to antigen. Specific antibody 
with receptors for macrophages or neutrophils 
may bind to antigen giving rise to enhanced 
phagocytosis of the antigen by the cell or in 
the case of cellular antigen to killer cell 
activity (ie) the target cell is directly 
killed by the macrophage or lymphocyte by means 
of a mechanism not presently understood.
Antibody may also bind to mast cells or basophils 
prior to binding with antigen resulting in the 
release of pharmacologic mediators from the cells
14
when binding to antigen takes place. This letter 
mechanism is a key part of immediate type 
hypersensitivity.
2.4 Cell-mediated Immunity
Cell mediated (or cellular) immunity is the part of specific 
immunity where the reactivities are wholly a feature of 
the cells themselves in that they can be carried out in 
the absence of soluble antibody, and the specificity is 
directed by 1he actual cells. The small lymphocytes involved
18
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are influenced by the foetal thymus either by contact 
with epithelial cells or by a diffusable substance 
elaborated by the thymus, or perhaps both, causing 
them to differentiate into various kinds of thymic 
lymphocytes (T-cells). (See figure 2). This normal 
response is important for normal protective mechanisms 
against specific organisms such as viruses, fungi, parasites 
and certain bacteria.
T-cells can affect antigen by three main routes (See 
figure 5) (probably only one effect is possible by any 
individual T-cell) namely
i) Direct attack on the antigen (target cell) - 
the killer cell effect,
ii) The elaboration of various factors which have 
a direct effect on the antigen, 
ii:^  The production of lymphokines - factors which 
attract other cells by chemotaxis and influence 
them to attack the particular antigen.
2.5 Complement
Complement comprises a system made up of nine distinct 
components (all proteins) which are present in the blood 
and tissue fluid of animals. The complement system 
constitutes a sequence of trigger mechanisms well suited 
to enlarge and diversify the effects of an antigen-antibody 
reaction. One of the important properties of complement 
is its ability to cause lysis of sensitised cells (ie. 
cells which have bound antibody) especially bacteria, 
through disruption of the cell membrane. (See figure 6).
19
FIGURE 5.
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FIGURE 6.
THE COMPIiElMT PATHWAY ; A CASCADE SYSTEM
A SYSTEM OF REACTIONS INVOLVING PROTEINS AND COFACTORS TRIGGERED
WHICH
FOLLOWING CERTAIN ANTIGEIf/ANTIBODY REACTIONS AND/IN TURN GIVES 
RISE TO MANY OBSERVABLE BIOLOGICAL EFFECTS. THERE IS A LARGE 
ELEMENT OF AMPLIFICATION IN THE PATHWAY.
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Other important actions of the system include release of 
anaphylatoxin, a poly peptide, which initiates local 
muscle contraction and vasodilation (an anaphylactic 
type response); enhancement of immune adherence to cells 
^hich facilitates ready ingestion and which attracts 
granulocytes to migrate to the site of the complex)and 
the stimulation of lymphokine production by lymphocytes.
2.6 Allergy
These systems which are normally immunoprotective can 
also be involved in immunopathologic processes where 
the system gets turned on and does not protect but is 
actually detrimental to the host. Four broad types of 
adverse reaction are recognised and are generally referred 
to as type I, II, III or IV according to a classification
15
put forward by Gell and Coombes in I968. (See table 2.)
The humoral antibody system is involved in three types of 
immunopathological reaction ie. types I - III reactions. In 
type IV or cell-mediated disease the T-cell system or 
cellular immune system is responsible for the reactions.
Types I, III and IV reactions (which may be present in 
the subject at the same time) may be demonstrated by skin 
tests. While type II allergy has a skin presentation 
it is not looked for in normal routine skin testing.
The term Allergy (an altered capacity to react) was
. 16
introduced in I906 by von Pirquet and applied to specifically 
induced reactions which were either enhanced or depressed.
The worci is nowadays used to mean altered reactivity 
which is increased above normal in response to an external
22
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noxious antigenic agent. Hypersensitivity, which implies 
a specifically increased capacity to react, is often 
used interchangeably with the term allergy. The antigenic 
agent which is capable of inducing a state of allergy in 
some persons is termed an Allergen.
An allergic reaction involves two (or more) contacts with 
the allergen:
i) an initial encounter by the individual of the 
allergen in which no reaction is apparent but 
as a oonsequence of which he is sensitized,
ii) a later encounter with the same material which 
triggers the allergic state causing a strong 
adverse reaction.
It is the process of sensitization which distinguishes 
allergy from irritation. Whilst the observed effect 
after encounter by a given allergen may be similar to 
that following encounter by an unrelated irritant the latter 
effect is not dependant on previous exposure of the individual 
to the substance concerned and does not involve the 
individual’s immune system.
It is clear that many substances possess both antigenic 
and irritant properties and that the observed response 
following exposure to these substances results from 
several reactions. The physical, chemical and biological 
properties of the substance (especially its concentration), 
the route and other circumstances of exposure, together 
with the immunological reactivity and previous medical
24
history of the person exposed will influence the particular 
response observed.
The metabolism of a given substance by the individual 
concerned is an additional factor. The body generally treats 
foreign substances as undesirable materials which must 
be excreted as soon as possible. The chemical transformation 
of the substance by degradation or enzymic metabolism 
(including hydroxylation, conjugation,reduction or oxidation) 
to create a more polar (ie. more water soluble) compound 
or compounds and thereby facilitate excretion is primarily 
carried out in the liver. The metabolite or metabolites 
produced may be immunologically significant especially 
if they have an ability to react with proteins or other 
macromolecular structures. Obviously a supply of these 
susceptible carrier molecules is essential for the metabolites, 
acting as haptens to form antigens; however, proteins 
synthesised locally within the liver are ideally suited 
to combine with newly formed reactive metabolites.
17
The traditional criteria for regarding a reaction as 
allergic (with or without supporting immunologic evidence) 
are as follows :
i) There is a history of previous exposure (without 
symptoms)- the period of sensitisation
ii) The degree of specific sensitivity may increase 
with further exposure
iii) A proportion, usually low, of exposed subjects 
are affected.
25
Generally allergic responses are elicited by dosages far 
less than those capable of sensitisation which in turn are 
usually far less than those capable of irritation. (See 
table 3)» Furthermore allergic responses occur only in a 
small proportion of persons exposed to the substance at 
a given concentration whereas responses to irritation are 
more likely to affect most exposed subjects and all are 
unrelated to previous exposure.
18
Atopic individuals appear to have a genetically determined 
capacity to produce specific IgE antibodies readily in 
response to the immunologic challenge presented by the 
ordinary, usually limited, exposures in daily life to
19-21
common allergens. They, show a higher incidence
and a far more rapid sensitisation to occupational agents 
•than do non-atopic subjects.
22
An individual’s immunological reactivity euch as.the . 
affinity or avidity of antibodies, produced and the 
capacity of con^lement to modify the solubility and handling 
of immune complexes may also have a bearing on responses. 
Affinity is the description of the interaction between a 
single antibody site and antigen (or hapten) - the higher 
the affinity of a given antibody the lower the concentration 
of antigen (or hapten) required to cause half of the antibody- 
binding sites to be occupied. Avidity relates to how well 
antibodies and antigens stick together and is dependant 
on additional features such as the number of binding sites 
the antibody molecule has for antigen and the number of 
determinants on the antigen.
26
TABLE 3
EXAMPLES OF TEE
BELATIVE QUANTITIES OF EEACTIVB CHEMICALS INVOLVED 
IN IRRITATION, ALLERGIC REACTIONS AND SENSITISATION.
Data for 3^
Toluene diisocyanate fumes
Irritant ^  0.5ppni
Allergic O.OO5 to 0.02 ppm
Data for 
Platinum salts
Irritant 10 ^ to 10 ^ g
Allergic 10 ^^g (approx 100,000 to 200,000 molecules)
27
2.7 Allergie Reactions
The response following reaction between allergens and 
sensitised cells is influenced by the particular mechanism 
triggered. The clinical manifestations observed in allergic 
reactions are not specific to the allergen involved.
In the immediate reaction (type I) IgE antibody bound to 
the surface of circulating basophils and to mast cells 
reacts with antigen and leads to structural changes in 
the cells (degranulation) and release of pharmacological 
mediators. These chemical messengers, in particular 
histamine and SRS-A (slow reacting substance of anaphylaxis) 
act directly on local tissues and organs such as the capillary 
network, blood vessels, secretory glands and nerve cells.
Histamine causes vasodilation in vascular tissue and 
increased permeability to plasma proteins thereby leading 
to inflammation, and contraction of smooth muscle leading 
to bronchDconstriction. SRS-A'also contracts smooth muscle.
Other mediators including prostaglandins and bradykinin 
also have vascular effects. IgE would seem to be a very 
rapid method for mobilising defence mechanisms locally.
It is unlikely that IgE has a significant role in any 
other way since the quantities apparently involved do not 
appear sufficient to neutralise or agglutinate antigen.
Type III allergic reactions involve circulating antibodies 
(primarily IgG) reacting with antigen in the blood stream forming 
immune complexes and activating the complement cascade. This in 
turn activates blood clotting mechanisms, liberates kinin and the 
release of proteolytic enzymes, permeability & chemotactic factors,
28
The involvement and role of mediators in late (type III) 
reactions has been less widely studied and is not fully 
understood. It is possible that some mediators could have 
pro-allergic or inflammatory effects in the immediate 
reaction but opposing effects in the late reaction 
(prostaglandins in particular show examples of this and 
appear to exert vascular effects at an early stage but 
effect cellular cAMP levels and other effects later.)
Many cases of respiratory allergy in particular appear to 
involve both an immediate and a late reaction commonly 
referred to as a dual response.
The true delayed reaction (type IV) is mediated by cells 
of the T-cell system, through the mechanisms described 
in section 2.4» The tuberculin-type skin reaction as 
observed in patch testing with allergens is the commonest 
indication of a delayed type reaction mechanism. The 
response develops slowly and reaches a maximum at 24 to 48 
hours.
There is however some evidence for a role for basophils 
and mast cells as well as serum antibodies in delayed
24
responses.Many delayed responses, including contact lesions, 
in animals and man are heavily infiltrated with basophils; 
some delayed skin reactions can be blocked by inhibitors 
of vasoactive amines (suggesting that mast cells or basophil 
mediators are involved in the pathology of the lesion) 
and contact sensitising agents can induce an antibody 
response including reaginic (igE) antibodies?^
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OCCUPATIONAL ALLERGY
3.1 Allergy and Work
Since allergic reactions may be precipitated by non- 
occupational agents, (just as all adverse effects of an 
occupational agent may not involve sensitisation), in view 
of the long latent period of exposure (over ten years in 
many cases) and the likelihood that other workers are not 
affected, the basic causal agents may go unsuspected 
and domestic or recreational environments may be implicated 
instead. Bemadino Ramazzini (a professor of medicine in 
Italy in the eighteenth century) was the first to publish^ 
a systematic account of trade diseases and highlighted 
the need to ask patients the important question ’What is 
your occupation?’ when undertaking clinical investigations.
Improvement in or cessation of symptoms at weekends or 
during holidays or following changes in work locations 
or occupation generally indicate an occupational origin 
for the &sease. Furthermore the rapid return of symptoms 
on resumption of work may suggest an allergic mechanism.
Allergic reactions caused by occupational agents giving 
rise to effects on the skin, the eyes or the respiratory 
tract have all been observed. Adverse reactions of the 
gastrointestinal tract also occur in food allergies, but 
are of little significance in occupational allergy. Whilst 
the observed reaction may indicate the organ or system 
in first contact with the agent this is not always the case 
(eg. respiratory disorders may result from general skin
30
27.30
contact with the agent or skin disease may follow from ingestion).
3.2 Respiratory Allergy
Adverse reactions of the respiratory tract include allergic 
rhinitis (eg hay fever),asthma and extrinsic allergic alveolitis 
(referred to as hypersensitivity pneumonitis in N, American 
terminology.) Although rhinitis is fairly common in the 
general population it has little significance in 
occupational allergy.
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Asthma, (defined as reversible obstruction of the bronchi 
and bronchioles) occurs in a wide variety of reactions
which fall into two main categories, as described below.
It can be caused by several factors unrelated to sensitisation 
including irritation. Immediate asthmatic reactions develop 
within minutes and can usually be associated with a particular 
causal agent. They rapidly reach a maximal effect and 
last about ij- to 2 hours. These reactions can be reversed 
by inhaled bronchodilator drugs and can also be blocked 
by the prior administration of sodium cromoglycate. 
Corticosteroids do not block the reaction. A "type I reaction 
mechanism is thought to be involved.
The other group are termed non-immediate asthmatic reactions 
since they develop slowly and often imperceptibly. The 
reaction may develop after 1 hour and last approximately 
5 hours or may come on after several hours reaching a 
maximum effect at 3 to 8 hours and last up to 24 hours.
They can be blocked by sodium cromoglycate and are also
31
effectively blocked by corticosteroids. However, they 
respond poorly to bronchodilators. In this case a type III 
reaction mechanism is thought to be involved. A further 
non-immediate reaction, recurrent nocturnal asthma, develops 
in the early hours of the morning following exposure and 
recurs without further exposure at the same time each 
night for several nights. This reaction responds poorly 
to all of the drugs.
The chief features of Extrinsic Allergic Alveolitis resemble
32
a viral or bacterial infection. They include chills, fever, 
sweating, malaise, anorexia, nausea, headache, chest tightness, 
a non-productive cough and dyspnea without wheezing 
developing from 4 to 6 hours after exposure. The symptoms 
resolve spontaneously in 12 to 18 hours but will recur on 
reexposure. Farmer’s lung and Bird fancier’s lung are 
forms of extrinsic allergic alveolitis. There is a decrease 
in the forced vital capacity (FVC) and one second forced 
expired volume (FEV^) of the lungs (See Appendix l).
Non atopic subjects usually exhibit this single stage 
response after short term exposure to the antigen to which 
they are sensitised. The reaction can be blocked by sodium 
cromoglycate but not by isoproterenol and can be improved 
by the use of corticosteroids.
A two stage reaction may be seen in atopic subjects.
Immediately after exposure there is a typical asthmatic 
reaction (type l) which is followed by a late type III reaction 
developing from 4 to 6 hours afterwards.
32
In some cases of a dual type response although the FEV^ 
decreases there is little change in FVC indicating that 
the physiological changes in the late phase are primarily 
obstructive involving the larger airways.
3.3 Skin Allergy
When the skin reacts adversly to the working environment
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it can do so in a variety of ways. Its commonest reaction 
is to become inflamed, a condition known as dermatitis or 
eczema. Inflamed skin looks red, swollen, blistered, 
weeping, flaky or cracked. It usually itches.
The commonest causes of occupational dermatitis are chemical 
substances in contact with the surface of the skin. This 
contact dermatitis may be caused by direct physical dam^e 
through irritation ie. acids, alkalis and organic solvents.
It may also be caused by sensitisation involving an 
allergic mechanism when the substance involved is referred 
to as a contact allergen or contact sensitiser. Many contact 
sensitisers do not feel harmful to the skin and their 
effect may take months or years to show. Dermatitis may 
also be caused by a phototoxic or photoallergic mechanism 
where the additional stimulus of sunlight or UV light is 
required in conjunction with the chemical agent.
Urticaria (blistering of the skin commonly seen in allergy 
to ivy or nettles) may also occur in occupational environments 
and be caused by allergic as well as non-allergic mechanisms.
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Adverse reactions to ingested materials (eg. food allergies) 
are commonly manifest by way of urticarial responses.
Other skin reactions occur to particular chemicals found
in the working environment eg. oil acne which looks
similar to teenage spots but is caused by excessive exposure
to mineral oil. (eg in machine workers in the engineering industry)
5.4 Allergy'- and the eye
The skin of the eyelids is susceptible to the same types
of hypersensitivity disorders and infections which involve
34
the skin of other parts of the body. Erythematous and 
exudative lesions may occur with scaling and crusting in 
later stages.
The other principal site in the eye involved in adverse 
reactions is the conjunctiva (the membrane covering the 
front of the eye). Contact sensitisation may produce 
conjunctivitis (inflammation of the conjunctiva) characterised 
by a papillaiy response, pronounced vasodilation, , 
oedema and watery discharge. Conjunctivitis is the chief 
ocular manifestation of many allergies to common airborne 
substances and is often seen in hay fever. A milky appearance 
and stringy exudate are characteristic of an allergic conjun­
ctivitis in contrast to the brilliant red appearance and 
purulent exudate found with bacterial conjunctivitis.
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Allergen in direct contact with the conjunctiva interacts 
with IgE hound to mast cells initiating the release of 
mediators (including histamine, slow reacting substance 
of anaphylaxis SRS-A, and phagocyte activating factor 
p a p ) which affect local blood vessels, smooth muscle and 
secretory glands and give rise to the clinical manifestations 
observed.
3.3 Properties of Allergens
With regard to respiratory allergies several factors 
predispose individuals to sensitisation by a particular 
agent; The nature of the organic dust or gas, the degree
17
of exposure, the immunologic status of the patient and whether 
they are smokers
The physical and chemical properties of a particulate or
gaseous antigen determine its immunogenicity. The size
of the particle determines whether it reaches the bronchioles
35
and alveoli where reaction occurs. Gases and volatile liquids 
will travel further than large particles. The solubility 
of the particle dictates whether it is absorbed by the 
lymphatics and blood vessels or phagocytosed by alveolar 
macrophages.
The intensity and duration of exposure are important aspects . 
influencing the occurrence and the mode of presentation of 
the disease. A certain degree of exposure over a given 
time may give rise to tolerance in some individuals. Exposure 
at a high intensity is likely to precipitate irritant 
phenomena in most individuals which will probably mask
35
allergie effects even when exposure is reduced.
Differences in the immunologic status of patients clearly 
influences their likelihood of being sensitised. The reason 
for only a few individuals in a particular group of exposed 
workers becoming sensitised to a given agent is not imderstood.
The reactivity of the individual is clearly different and 
this may stem from a variety of reasons including genetic
18:36
factors. The concept of atopy is part of this. Evidence
suggests that most workers exposed to a particular chemical ; .
are likely to develop antibodies to it without becoming
sensitised. The elicitation of a type III response to a
particular antigen by some individuals in contrast to
others developing a type I or dual response further
illustrates this difference.
3.6 Sources of Occupational Allergens
Even in occupational environments sensitising agents arise 
from animal or vegetable sources (including micro-organisms) 
or from non-living (industrial) chemicals, (see table 4.)
In the case of living or dead animal matter and with fungi 
and bacteria the allergens are generally proteins (including
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TABLE 4 : OCCUPATIONAL ALLERGENS
SUBSTANCES REPOKDED AS GIVING RISE TO CASES OF SEITSITISATION 
TO WORKERS IN VARIOUS OCCUPATIONAL ENVIRONMENTS.
Al^IMAL SOURCES
Animal dander - hair, epidermal squamae,
42 - 49
urine, faeces
* h 50- 6 2Arthropods
VEGETABLE SOURCES
-r,-, o j. 63-66Flour dust
_ . . _ 67;68
Cotton seed
_ , 69:70
Castor bean
' « . . . 62; 71
Grain dust
72 - 74
Garlic
Gums
Soybean dust
77-84
Western Red Cedar wood dust 
Other wood dusts
^ , . 93 - 100
Colophony resin
_  . 101 -103 
Papain
104-106
Coffee bean
107 r 1 0 8
Henna
Mushrooms
Bromelain (from pineapple)
112 :113
Flax seed
11 2 : 11 3
Hemp
113
Maiko
37
TABLE 4 CONTUSED : OCCUPATIONAL ALLERGENS
MICR0-0RGANISI4 SOURCES
1l4pi5-1l8
Spores of thermophyllic and other actinonycetes
119-124
Spores of other fungi — ?specially Aspergillus spp.
8 ; 125-131
Enzymes of Bacillus subtilis (used in detergents)
132- 133
Antibiotics derived from Pénicillium spp.
NON-LIVING (INDUSTRIAL) SOURCES
21:134-138
Platinum salts
139
Chromate salts
140
Nickel salts
141
Phenyl mercuric compounds
142
the tic fibres
108
Persulphate salts
37: 143-153
Epoxy resin systems
154-171
Isocyanates
172-175
Acrylates
176-179,333
Reactive dyes
Other reactive organic chemicals (See Tables 5 to 9)
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enzymes) or macromolecules. Inorganic (mineral) or 
simple organic chemicals found in industrial or other 
occupational environments are increasingly being implicated 
as sensitising reagents.
Ultimately the chemical nature of the agents is important 
rather than its source. The causal agents of allergic 
reactions due to wood dust and pine resins have been
41
identified as simple organic chemicals. Obviously in the 
case of animal matter, micro-organisms, spores etc. several 
proteins and other chemicals intimately combined may be 
involved as the causal agent making extraction and identification 
of individual chemicals extremely difficult.
3.7 Diagnosis of Occupational Allergy
Identifying the causal agent and establishing the aetiology 
of a disease may be difficult but defining its pathogen .sis 
(ie. the actual development of the disease) can be very 
involved and apparently impossible yet this must be 
achieved in order to promote successful treatment of patients 
and in prevention of further cases of the disease.
To ascertain a proper diagnosis of a disease involves not 
only detailed questioning and clinical examination of the 
patient but also appropriate physical testing (lung function, 
bronchial provocation and skin tests) and immunological 
investigations. (Appendix I summarises test procedures.)
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Bronchial provocation tests in asthma and allergic alveolitis 
are a pragmatic means of aetiologic diagnosis that, at the 
same time, reproduce some or all of the clinical manifestations. 
In this respect the test reactions provide models of the 
clinical disorder and are useful in trying to interpret 
the variable history, in particular of clinical asthma.
By delivering controlled amounts of the suspected offending 
material either by aerosol nebuliser and face mask or by 
inhalation of vapour in a closed environment, or as a dust 
diluted in lactose powder,one can repeatedly determine 
respiratory function and obtain valuable information about 
patterns of bronchial reactivity as well as the effect 
of therapeutic agents. Unfortunately bronchoprovocation 
challenge testing affords little useful information concerning 
underlying immunologieal or non-immunological mechanisms#
The use of various treatment drugs in connection with 
provocation challenge testing provides some additional 
information as to the aetiology and pathogenesis of a 
particular disease.
Experimental, challenge-induced, immediate asthma readily
responds to treatment with beta adrenergic stimulants
such as iso-proterenol but not to inhaled or systemic 
180
corticosteroids. On the other hand, late asthmatic reactions 
due to occupational agents characterised by an interval 
of one to two hours between exposure and onset of
40
respiratory symptoms and prolonged asthmatic response can
be inhibited by corticosteroids such as beclomethasone 
181
dipropionate. These late reactions also respond partially
but poorly to beta-adrenergic stimulants. In other cases
when dual, early and late asthmatic reactions occur both
the immediate and late components can be prevented by
prior administration of sodium cromoglycate some minutes
182
before bronchial challenge. This drug, which was originally 
shown to protect a sensitised subject against an asthmatic 
reaction induced ty the inhalation of house dust extract 
appears to inhibit the release of pharmacological mediators in man 
but apparently does not prevent antigen-antibody interaction.
3.8 Common Occupational Allergens and Their Effects 
The following paragraphs in this section summarise the 
observed effects of some of the organic chemicals which are 
common occupational allergens and of the substances 
containing them. More detailed information on the effects 
of particular chemicals identified as causal allergens 
is contained in Tables 5 to 9 arranged according to the 
structure of the molecule concerned.
Allergic responses to epoxy resin or its constituents have 
been widely reported. Epoxy resin systems are amongst the 
most important causes of industrial contact dermatitis.
The uncured resin is the commonest cause but curing agents
146:l49;i5i:i83-187
and even the cured resin may cause dermatitis. Cases of
37:144:145 :147:148; 150:152:153
adverse respiratory symptoms have also been documented.
41
Epoxy resin systems have two basic components, the uncured 
resin and a curing agent or hardener. The resins vary 
in composition but all are long chain polymers commonly 
produced as condensation products of epichlorohydrin and 
bisphenol A and they vary from low viscosity liquide 
to solids depending on molecular weight. The resins are 
relatively stable in themselves but contain terminal 
reactive epoxy groups and side chain hydroxyl groups. The 
resins are converted to hard solids by the addition of a 
curing agent or hardener. In some systems external heat 
is necessary and these commonly use acid anhydrides as 
curing agents while others are cold curing, notably 
those using amine compounds. In either case curing of the 
resin is brought about by chemical splitting of the 
epoxy ring leading to cross linkages between the long 
chain resin molecules producing macromolecular three 
dimensional structures. During the curing process fumes 
of resin and curing agents are emitted.
It seems likely that the pulmonary hypersensitivity reactions 
result from the presence of curing agents such as polyamines 
(diethylenetriamine, triethylenetetramine, piperazine) or 
acid anhydrides ^ hthalic anhydride) rather than the polymer
37
itself.
The sensitisation by anhydrides is discussed in detail 
in Chapter 5*
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Investigations of the allergenicity of epoxy resins and 
the sensitising capacity of their constituents using
188 - 192
guinea pigs has shown that epoxy resins of low molecular 
weight (540 daltons) is a potent sensitiser in these 
animals and that the sensitising capacity decreases in 
inverse proportion to the increase in average molecular 
weight of the resin mixtures.
Isocyanates are widely used in industry for the production 
of several products including polyurethane foams and 
are known to have toxic effects. They are mild skin
193-195
irritants and sensitisation of the skin can occur. In 
sufficiently high concentrations isocyanates have a primarily
196 - 198
irritant effect on the respiratory tract causing dry throat 
and coughing. Asthmatic attacks may result and may occur
199 -201
immediately on exposure or some hours later, Some workers 
(about 5^ of exposed persons) may become sensitised.
The two most common compounds are toluene di-isocyanate 
(TDI) and diphenyl methane di-isocyanate (MDI). Immediate, 
non-immediate and dual reactions to TDI have been observed
171:202:204-206
and it has been shown to induce recurrent nocturnal asthma.
179:207-217
The use of ultra violet cured inks has given rise to 
allergic reactions in exposed workers. The ink usually 
consists of one or more conventional pigments dispersed 
in a polymeric vehicle. Included in this vehicle are 
polyfunctional acrylate monomers such as trimethylol 
propane triacrylate (TMPTA), pentaerythritol triacrylate
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(PETA) and hexanediol diaciylate alone or in combination 
with monofunctional acrylic monomers such as hydroxy ethyl 
acrylate or 2 - ethyl hexyl acrylate. Other constituents 
include UV reactive unsaturated polymers (often also 
acrylated materials), photoinitiators (eg. benzophenone), 
diluents (alcohols cr phthalates), hydrogen transfer agents 
(eg. triethanolamine) and miscellaneous additives (including 
stabilisers, surfactants etc.) The UV radiation is absorbed 
by the photoinitiators resulting in the generation of free 
radicals which in turn cause polymerisation of the resin 
in which the pigments are incorporated and thus cures the 
ink film.
TI’^IFA and PETA are known to be strong allergens and cross 
reactivity between them and other acrylates has been
219 *
demonstrated. The principal symptom is an erythematous 
pruritic rash and since its distribution on affected 
workers generally includes the face and neck as well 
as the hands and arms, it is suggested that airbornematerials 
play an important role in eliciting the reaction.
Allergic contact sensitisation to several monofunctional
215-222:417
acrylic monomers has also been widely reported, with methyl 
methacrylate most frequently incriminated although acrylonitrile 
acryl amide, ethyl hexyl acrylate and N tert butyl maleamic 
acid have been cited.
Resins used in the Letterflex printing process, which also
223 -226
uses UV light to trigger polymerisation, are reported as allergens
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However a polythiol (commonly pentaerythritol tetrakis 
3 mercapto propionate) seems to be the chemical responsible. 
Two types of symptoms are known
i) Skin lesions - some of an irritant pruriginous 
and erythematous nature appearing on uncovered 
parts of the body; others of an eczematous 
nature primarily affecting the hands,
ii) General symptoms including various degrees
of conjunctivitis and respiratory disturbances 
with sneezing and rhinorrhea or conversely, 
nasal obstruction, coughing, dyspnea, and 
true asthmatic attack.
227- 233
Amines present in the rubber of tyres have been reported 
to cause allergic contact dermatitis in exposed workers. 
K-isopropyl-N phenyl paraphenylene .diamine (iPPD) and 
related compounds in particular give rise to eczema 
characterised by distinctly vesicular lesions on the backs 
of hands and forearms. Some cross reactivity occurs.
Occupational asthma due to sensitivity to colophony fumes
93-100
have been reported. Colophony, which has been used as a 
soldering flux since ancient times, is the residue left 
after turpentine has been distilled from pine resin. It 
consists largely of abietic and pimaric type resin acids, 
the exact composition depending on the source of the 
material.
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The common symptoms are wheezing, breathlessness and cough; 
sputum, rhinitis and eye irritation have also been observed. 
The wheeze and breathlesness generally persist after 
work in the evening. Bronchial provocation testing in 
sensitised workers generally elicits both immediate and 
late asthmatic reactions. Colophony itself is also a potent
234-236 ;411 :412
skin sensitiser.
87 ; 237
Asthma due to inhalation of wood dusts is generally an 
irritant phenomenon. However, asthma caused by occupational
77-84
exposure to dust from Western Red Cedar has been reported 
and appears to be a respiratory allergy. The syndrome includes 
chest tightness, dry irritating cough and wheeze (becoming 
worse at the end of the day) followed by nocturnal cough 
and wheezing. Nocturnal symptoms often persist for several
414
days after cessation of exposure.A type 1 reaction is 
thought to be involved and the principle allergen (hapten)
41
has been identified as plicatic acid.
Cases of other wood dusts acting as respiratory allergens
85-92 87:88 ; 238 - 243 : 413
have been reported and many woods are known to be contact 
sensitisers.
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STRUCTURAL BASIS OF ACTIVITY 
4*1 Functional Groups
Whilst physical factors (eg. particle size, solubility, 
volatility etc.),.concentration and route of ’invasion’ 
of the causal agent are important, structure and 
molecular configuration are the key factors which 
affect the elicitation of a particular response. Indeed, 
since all biological activities are primarily effected 
by chemical means, the interaction between molecules 
(or more precisely between functional groups present 
on the molecules) is an essential precursor of the 
observed response.
At the molecular level, chemical reactivity is determined 
by the presence of particular functional groups and 
their relative accessibility. The accessibility of a 
given functional group present on the molecule is a 
consequence of its three-dimensional structure which 
determines whether it is inhibited from exerting an 
appreciable affect by the location of other atoms or 
groups (steric hindrance) or remains free to react with 
other molecules. The greater the complexity of the 
molecule the more likely it is that certain groups 
will be prevented from acting. Conversely and more 
importantly in such molecules two or more functional 
groups are likely to be brought together on the surface 
of the molecule forming an ’active site’, this is
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particularly relevant in the case of proteins and other 
macromolecular substances and indeed constitutes the 
veiy basis of enzyme action.
Clearly the chemical composition and structure ultimately 
determines the three-dimensional configuration of the 
molecule. With small molecules the active functional 
groups are easier to determine but when conjugates are 
formed (eg. between haptens and carrier proteins) the 
reactivity of the resulting complex will be influenced 
not only.by the remaining accessible groups of the 
smaller molecule but also by the groups of the larger 
molecule in close proximity to it.
Key functional groups present on molecules of substances 
which have given rise to allergic and other adverse 
reactions in man (or experimental animals) include the 
carbonyl-, amino-, and amido- groups as well as the 
presence of unsaturated centres in certain molecules. 
Obviously the close proximity of other groups to these 
key groups, either linked chemically or simply by position, 
will modify the reactivity of the key group.
Tables 5 to 9 summarise the observed symptoms of adverse 
reactions in humans (and in animal studies) following 
occupational exposure to particular organic chemicals 
containing one or more of these key functional groups. 
Adverse reactions which have not been shown to involve 
sensitisation (either by direct immunological evidence 
or by implication following the usual criteria) have not
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TABLES 5 TO 9
A SUMMARY OF THE OBSERVED REACTIONS TO, AND THE EFFECTS 
OF, SMALL MOLECULAR WEIGHT ORGANIC CHEMICALS PRESENT IN 
CERTAIN INDUSTRIAL AND RELATED WORKING ENVIRONMENTS.
TABLE 5: CARBONYL COMPOUNDS PAGE NO.
5a Aldehydes 49-50
5b Quinones 51-53
5c Carboxylic acids 54-55
5d Acyl halides 56
5e Amides 58
TABLE 6: UNSATURATEO COMPOUNDS
6a Acrylates 59-60
6b Methacrylates 61
6c Acrylamides 62
6d Isocyanates 63-64
6e Reactive dyes 65-66
TABLE 7: COMPOUNDS CONTAINING STRAINED RING SYSTEMS 
7a Epoxides 67
7b Imides 68
TABLE 8: AMlWES 69-71
TABLE 9: THIOLS 72
Structural Formulae, Index number,Solubility and Physical 
Data from the Merck Index ]Oth Edition 1983.^ '*'^
Long Term Exposure Limits (LTEL),Short Term Exposure Limits
245
(STEL) from Guidance Note EH 40 (Health and Safety Executive),
TABLE 5a ALDEHYDES
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been included. Reports of allergic contact dermatitis 
to related chemicals have been included for comparison 
purposes.
4*2 Bonding to protein
Strength or stability of bonds between a carrier molecule 
and a small hapten plays a critical role in the determination 
of its biological properties. Since haptens have to form 
stable complexes with carrier proteins in order to react 
with the immune system it has long been accepted that
368,369
covalent binding of these units is necessary. Weaker bonds 
(ionic or dipole including hydrogen bonding) can serve 
only when multiple bonds provide the necessary cumulative 
energy to the complex.
Carbonyl, amino and similar groups on haptenic molecules 
are therefore prime candidates for this task. Reactive 
anhydrides, quinones and acid chlorides have been shown 
to form hapten-protein conjugates by linking of their 
constituent carbonyl groups with amino groups of amino 
acid residues of protein. Similarly the isocyanate group 
of the various reactive aliphatic and aromatic isocyanates 
known to induce allergic reactions, is thought to be
38
responsible for covalent attachment to protein. TDI is
370
capable of combining with -SH and -COOS groups
as well as undergoing self polymerisation and still
371
retaining reactive isocyanate groups. In the case of 
10
reactive dyes covalent bonding between heterocyclic
74
halogen groups on the molecule and amino or hydroxyl
10
functions of protein side chains can occur. Indeed this 
type of linkage is used in the dyeing process.
The reactive side chains of amino acid residues commonly 
present in proteins and likely to be involved in protein 
binding to haptens are shown in table 10. The structures 
of probable haptens formed by several classes of reactive 
organic compounds with protein (linked via side chain 
groupings) are shown in figure 7.
The presence of unsaturated bonds in haptenic molecules 
does not seem to influence protein binding. In the case 
of abietic acid and pimaric acid (found in colophony 
resin) the unsaturated double bonds of these acids seem 
to be less important for protein binding than the
95 156
carbonyl groups. Similar evidence has also been found in 
the case of TDI.
4.5 Conjugates
Molecules with more than one functional group capable 
of binding to protein may give rise to several different 
conjugates. Even with a given protein a molecule with 
two or more of the same functional groups may form two or 
more conjugates of separate structure. The position is 
further complicated in the case of molecules having 
different functional groups. With plicatic acid (found 
in Western Red Cedar) for example, carbonyl groups on 
the molecule could bind with lysine or arginine residues 
on a given protein to form a complex whilst alternatively
75
TABLE 10.
REACTIVE AMINO ACID SIDE CHAINS . , _ OF PROTEINS AVAILABLE
FOR BINDING TO REACTIVE ORGAITIC MOLECULES
SERINE HO-CHz-
THREONINE CH3-ÇH  
OH
TYROSINE
HO W // C H ,-
EYDROXYPROLINE H O
1 3N
H
COOH
ASPARTIC ACID HOOC-CH,-
GLUTAI^IC ACID HOOC-CHz-CHg-
ARGININE
NHz-C-N -CHz-CHz-CHz 
H
LYSINE NHz-CHz-CHz-CHz-CHz-
SISTIDINE CH =  C -C H ,-
I I
TRYPTOPHAN
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FIGURE 7.
STRUCTURES OF PROBABLE HAPTEl^S RESULTING FROM THE REACTIONS
OF SIMPLE ORGANIC CHEMICALS WITH PROTEIN. (B)
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FIGURE 7. (continued) 
STRUCTURES OF PROBABLE EAPTEUS
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other functional groups present may be capable of 
binding with separate amino acid residues on different
372
proteins to form other complexes. Studies on plicatic 
acid using a human serum albumin conjugate (linked to the 
carboxyl group of the acid by an amide bond) seem to 
indicate however that the protein in vivo is connected 
not by this linkage but through one of the groups in 
the catechol ring (possibly an hydroxyl group.)
The availability of a particular protein at or near the 
site of invasion into the body by the reactive chemical 
will clearly determine which conjugate or conjugates 
are formed. Since a particular agent entering via the 
lungs is likely to encounter some different proteins 
to those found when entering via the skin a totally 
different conjugate is likely to be produced at each 
site which in turn may lead to different types of reaction 
being elicited at each of the sites concerned.
Any given carrier protein molecule is likely tohave 
several side groups capable of combining with molecules 
of the invading haptenic chemical and accordingly the 
conjugate formed is likely to consist of many haptenic 
residues joined to a single protein. The total number 
of residues joined would be expected to be influenced 
by the relative local concentrations of hapten and carrier 
protein, the number of available reactive groups of the 
appropriate type on the protein and their accessibility 
to the hapten molecules.
79
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In one study involving a TDI-HSA protein conjugate the 
molecular ratio of the complex was found to be 34 molecules 
of isocyanate per molecule of protein. However, in a similar
3 7 4
study also using TDI-HSA conjugates it was found that 
conjugates with 18 to 20 molecules of isocyanate per molecule 
of protein were more potent antigens than those with greater 
isocyanate content.
The significance of this is not clear. It is possible that 
with a large number of haptenic residues on a protein some 
cross-linking may occur thereby effectively changing the 
structure of the conjugate and therefore the functional 
groups capable of acting as an antigenic determinant. 
Alternatively, a large number of haptenic residues together 
may reduce the antigenic potential purely through steric 
hindrance of certain key groups.
Investigations of the mechanism of isocyanate hypersensitivity
367:382 -  3 8 6
have been undertaken by several groups of workers involving 
animal studies using mice or guinea pigs. Various hapten- 
protein conjugates have been employed as test antigens 
to stimulate allergic reactions and to investigate the 
specificity of antibody produced by isocyanate sensitised 
workers or test animals. Mono isocyanate compounds have 
generally been used for antigen formation in preference to 
diisocyanates to avoid cross-linking of proteins in conjugate 
formation.
80
The results generally indicate that the isocyanate group 
is involved in protein binding via an ureido linkage probably 
with lysine side chains. Other parts of the isocyanate 
molecule are involved as part of the antigenic determinant. 
Additional isocyanate groups (as in the diisocyanate molecule) 
probably in vivo engage in crosslinking proteins and 
therefore form complex antigenic determinants.
387
Studies of acrylates and methacrylates in the guinea pig 
suggest that the presence of an alpha carbon group in the 
latter molecule decreases its sensitising potential when 
compared to its acrylate analogue. This may be due in part 
to steric hindrance affecting the reaction of active groups 
on the molecule with protein. The linkage to carrier protein 
would be expected to be formed by displacement of the 
alkyl group at the alkoxy linkage.
C H=C H :C -0-R
5
C H ,= CH“ C-0*RI ^  
NH,
1? +
C H |= C H -C -N H - P
-H+
n H
C H=CH-C-N- P
This steric hindrance effect could be acting by decreasing 
the protein binding potential and so reducing the creation of a. 
potential allergen conjugate in the first place.
81
The methyl group could also be affecting the reactivity of the 
molecule generally and its susceptibility to attack by 
protein side chain groups.
Similar evidence has been found from other studies. Comparison 
of the reactivity of a series of alpha alkyl substituted
388
cinnamaldéhydes towards primary amines showed that the 
substituted aldehydes reacted very slowly compared to 
cinnamaldéhyde itself. Since the reaction between aldehyde 
and amine corresponds to that between aldehyde and the 
-NH^ group of protein this evidence suggests that the 
substituted aldehydes will not react readily with proteins 
and that conjugate formation is unlikely. Indeed the substituted 
aldehydes are found not to be sensitisers. In this case the 
substituent is thought to reduce the chemical reactivity of 
the aldehyde group.
219
Patients sensitised to acrylates in adhesive tape were found 
to exhibit a broad cross-reaction pattern with acrylic 
esters yet failed to respond to methyl methacrylate. In 
particular they reacted readily to 2-ethyl hexyl acrylate but 
did not respond to the methacrylate analogue. The methacrylate 
compounds may have only reacted weakly with protein (if at 
all) and not formed a strong complex which the *acrylate 
receptors* in the sensitised patients could recognise.
4.4 Active Sites
Obviously the site of the chemical linkage between the 
invading chemical and the carrier protein influences which 
other parts of the molecule function as the relative
82
antigenic determinant for the induction of, and auheequent 
reaction with, specific IgE antibodies in sensitised workers. 
In the case of very small molecules, the whole of the 
invading chemical moiety (including groups linking it to 
protein) as well as part of the protein itself are likely to 
constitute the antigenic determinant.
With larger and more complex molecules this may not be the 
case and indeed only part of the chemical may be involved in
321
the active site. Evidence from animal studies on acrylates 
for example, suggests that the alcohol part of the ester 
molecule is not involved in influencing the sensitising 
potential of mono acrylates.
However, since binding of the hapten with carrier protein is 
an essential prerequisite of the observed allergic response 
it is probable that groups on the protein constitute an 
essential part of the active site. Indeed, several studies 
have shown that the specificity of antibody produced in 
response to protein conjugates is directed not only against 
the chemical groupings attached to the protein but also 
some of the amino acid residues of the carrier protein.
304
Studies on workers hypersensitive to phenyl glycine acid 
chloride indicated that the specific antibody produced 
to the complex formed recognised part of the protein molecule 
extending beyond the hapten and the lysine residue of the 
protein molecule through which it was joined.
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JJn CHjCHjCHjCHjR
y
u y Ç - C  N CH^CHgCHgCHgR + CL"
NH, H
H* // / ? c n c h c^ h ,c h ,c h ^r  
N H gH
Similarily in the case of allergy to trimellitic anhydride
3 8 9
it has been demonstrated that the antigenic determinant 
involves at least one amino acid of the carrier protein 
as well as groups on the hapten part of the conjugate.
3 7 6
In studies on respiratory hypersensitivity in the guinea 
pig the animals were exposed to an aerosol antigen using 
p-arsanilic acid and p-tolyl diisocyanate as haptens 
coupled with ovalbumin or bovine serum albumin. The hapten- 
specific nature of the pulmonary reactions was demonstrated 
by a) a response to challenge with hapten-protein conjugates 
and the lack of response to challenge with protein carrier 
alone, and b) by reactivity upon challenge with hapten 
coupled to unrelated heterologous carriers.
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The active site and the antigenic determinant formed I 
(which ultimately triggers the allergic response) by one 
hapten conjugated with a given protein may be similar to 
that formed by a different hapten conjugated with an 
alternative protein. The essential point being that the 
position and pattern of accessible functional groups present 
on the conjugate and so available to react with antibody need 
to be the same or very similar.
Indeed, cross reactivity between isophore diamine and .
390
isophore diisocyanate has been observed: this would tend to 
suggest that the part of the molecule reacting with antibody 
does not contain an isocyanate group, and if the isocyanate 
group is employed in binding to carrier protein and the 
amine groups of the diamine undertake a similar role then 
different protein-hapten links will be formed. However, 
the active site produced in the two cases could still be 
similar and may account for the observed results.
The functional groups present at an active site (whether 
from the hapten or carrier protein parts of the complex) 
must stimulate a reaction with receptors present on the 
appropriate circulating memory cells in order for 
antibody to be produced and an allergic reaction to be 
triggered. These groups, like those involved in binding 
to the carrier, will need to be polar thereby enabling 
them to induce reactions with amino, hydroxyl and similar 
groups et the receptor site.
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Unsaturated carbon chains also appear to be involved as 
part of the active site in some haptens (eg. acrylates 
and isocyanates) and not for conjugate formation. Non­
reactive saturated carbon chains are unlikely to stimulate 
reaction with receptors.
The majority of haptens detailed in tables 5 to 9 have 
more than one functional group thereby providing for at 
least one group to be involved in binding to carrier protein 
and one or more groups for acting as the active site.
The groups involved in the conjugate formation could still 
be part of the active site but their influence would be 
much reduced. However, in the case of formaldehyde, for 
example, with only one functional group it must be involved 
in both activities and may induce an antigenic determinant 
merely by altering the local configuration of the carrier 
protein.
Diamines may react by cross-linking proteins or parts of 
proteins to form key groupings which constitute the antigenic 
determinant.
As indicated above whether one haptenic residue on a carrier 
protein constitutes one antigenic determinant or whether 
several haptenic residues on the one protein in close 
spatial proximity are needed is not clear. With smaller 
molecules the latter case is more likely since the slight 
change in protein configuration brought about by joining 
of an odd group or two is likely to be of marginal significance.
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Cross reactivity between related chemicals provides some 
information about functional groups implicated as antigenic 
determinants or as part"of the active site. In cases of 
allergic contact dermatitis, patients sensitised to one 
particular chemical often give positive skin reactions 
to related compounds. However, it is difficult to conclude 
that the observed response to the related chemicals is 
indeed mounted by the same antibodies as those to the 
original sensitiser or whether the patient is actually 
sensitised to each of the chemicals being tested. This 
latter situation may well prevail in susceptible individuals 
where a particular working environment exposes them not 
only to the principal chemical but also traces of related 
chemicals (possibly present as impurities) to which they 
also become sensitised.
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ACID ANHYDRIDES
5.1 Introduction
Anhydrides are widely used in industry. In particular they 
are one of the principal- types of curing agent (hardener) 
used in the manufacture of epoxy resin plastics. Epoxy 
resin, made by polymerising a phenol and epichlorhydrin, 
will polymerise spontaneously at high temperature but the 
process is expedited by hardeners or curing agents. Curing 
of the resin is brought about by chemical splitting of the 
epoxide ring leading to cross linkage between the long 
chain resin molecules producing three-dimensional structures. 
External heat is often necessary but the reaction is 
generally exothermic and during the curing process fumes of 
resin and curing agent are emitted. (Amines and polyamides 
are also used as curing agents.)
Phthalic anhydride is used in a wide variety of industrial
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processes; 60^ as plasticiser in vinyl chloride polymerisation; 
30^ for polyester resin manufacture and in pesticides, 
essences and perfumes; 10^ in the production of alkyd resins 
in paints and lacquers and in the preparation of benzoic 
acid. Trimellitic anhydride is also used as a raw material 
in the manufacture of plasticisers and in the production of 
resins with hydroquinone and aromatic diamines.
Dermatitis to epoxy resin systems and their components
392
(including anhydride curing agents) is well known. The 
presentation of dermatitis may be either acute or chronic.
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Acute cases show marked oedema of the face and eyelids or 
of the hands and genitalia, sometimes with large blisters or 
exudation of serum - suggesting a contact dermatitis from 
allergy to vapourised resin. Subacute or chronic cases more 
usually affect the hands and fingers as areas of red, scaly 
papulovesicular dermatitis but sometimes show lichénification 
fissuring or psoriasiform appearance - often difficult to 
diagnose without patch tests and may be due to direct contact 
with the resin or hardener.
5.2 Respiratory sensitisation
Cases of respiratory sensitisation to four common anhydrides 
(phthalic anhydride, tetrachlorophthalic anhydride, 
trimellitic anhydride and pyromellitic dianhydride) have 
been reported. Formulae and a summary of the observed 
symptoms are given in table 5e. Case histories of 3 workers 
apparently sensitised to anhydrides are summarised in 
figures 8,9 & 10.
Phthalic anhydride is a recognised irritant to the respiratory 
tract and asthma often develops. Several cases of asthma due 
to hypersensitivity to the powder and/or its fumes are
305 393
known - the earliest report being by Kern in 1939. Recently 
phthalic anhydride has been implicated as one of the causal 
agents responsible for 'meat wrapper's asthma'.
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Tetrachlorophthalic anhydride is aisoi known to cause 
sensitisation giving rise to a clinical and physiological 
response indicative of a combined immunologic reaction.
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FIGURE 8.
CASE HISTORY OF PATIENT WITH APPARENT RESPIRATORY ALLERGY TO
148
AN EPOXY ADHESIVE COITTAINING PYROMELLITIC DIANEYDRIDE AS HARDEI^R
The patient had worked with an epoxy resin cured with pyro­
mellitic dianhydride powder, including the mixing of the chemicals 
and curing of the mixture at 180*C. She had no previous history 
of hay fever or asthma prior to using the adhesive and did not 
experience dyspnea on exertion or chronic bronchitis. Whilst 
she experienced nasal symptoms and wheeze using the adhesive 
they were much more severe when she mixed it. *
Respiratory function tests were undertaken at the workplace.
The first reading and one taken 30 minutes later were used as 
a baseline and subsequent readings expressed as a percentage 
of it. FEV^ and FVC were repeated at intervals of 10,20,30,60 
and 120 minutes after exposure to the mixed adhesive. The 
subject declined to be tested when mixing the adhesive. The 
results are tabulated below.
The subject was also tested after inhaling cromoglycate at 
20.30 hours the previous evening and 06.00 hours on the morning 
of the test. The results (as shown on the graph below) indicate 
little benefit from its use.
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FIGURE 8 (continued).
CASE HISTORY OF PATIEITT WITH APPARENT RESPIRATORY ALLERGY TO
AN EPOXY ADHESIVE CONTAINING PTRGMELLITIS DIANSYDRIDE AS HARDENER
USING MIXED ADHESIVE 
Nasal symptoms 
Respiratory symptoms 
Time of v/heeze (minutes) 
Fall in FEV^ (^)
Time of fall (minutes) 
DURATION OF EXPOSURE (MONTHS) 
ORIGINAL FEV^ (LITRES)
+
+
45
15
10
12
1.97
The subject vas not atopic, did not smoke and gave negative 
results on prick testing.
FEV,%
baseline
105 adhesive
100
95
adhesive after 
cromoglycate
90
85
60 m inutes 1 2 0
Change in FEV^ as a percentage of base-line values
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FIGURE 9.
CASE HISTORY OF PATIENT WITH ASTB'IA DUE TO SENSITISATION TO
37
PHTHALIC ANHYDRIDE
The patient worked as a tool setter in a plastics factory- 
specialising in plastics moulding. He had been free of illness 
until 10 years previous,since when he had minor episodes of 
acute bronchitis without wheezing,attributed to upper 
respiratory tract infection. He had smoked 20 cigarettes per 
day all his working life.
He was responsible for setting up a new machine for encapsulating 
electrical coils in epoxy resin. The process used a moulding 
powder of blended epoxy resin with phthalic acid anhydride as 
curing agent. The powder was fed from a hopper into the mould 
of the machine around the coil, where it was heated to 150*0.
The worker was exposed to large amounts of the fume produced.
He collapsed with severe asthma whilst operating the machine 
some five months later (although he had no chest symptoms in 
the meantime) and was admitted to hospital. Asthma recurred 
when he started work again and followed immediately after 
exposure to the moulding powder fumes. He was subsequently 
transferred to a different job.
He was referred for inhalation challenge testing sometime 
later, and at the time of the investigation had not been 
exposed to the fumes for 5 months but still experienced 
occasional wheezing.
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FIGURE 9 (continued).
CASE HISTORY OF PATIENT WITH ASTHMA DUE TO SENSITISATION TO 
PHTHALIC ANHYDRIDE
The results of pulmonary function tests are tabulated below, 
and the results of the inhalation challenge expressed graphically.
FEV^ (ml) 
FVC (ml)
f e v ^/f v c (^)
VC (ml)
FRC (ml)
TLC (ml)
Actual
2880
5180
55.6
4950
5490
9190
io Predicted
79
104
99
129
125
Immediate asthmatic reaction to one breath of fume from phthalic 
acid anhydride-epoxy resin (••-») Control with epoxy resin 
only (#— #) No reaction to a toluene diisocyanate system (•...«)
3-0
2-5
—  2-0
wu.
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FIGURE 10.
CASE HISTORY OF PATIENT WITH APPARENT RESPIRATORY ALLERGY
311
TO TRIMELLITIC AITHYDRIDB (TMA)
The patient had worked for several years in the bagging area 
of a TI'IA plant. After a few months of exposure he developed 
nasal pruritis, rhinorrea and conjunctivitis to the TMA dust. 
After a period of years he began to have respiratory symptoms 
on the job consistent with asthma. He used an isoproterenol 
inhaler to help him through the work shift. As the symptoms 
progressed he noted wheezing which persisted throughout the 
night with cough dyspnea and associated arthralgia, myalgia, 
chills and fever and was subsequently removed from work.
Six months later pulmonary function studies were undertaken 
both before and after a ten minute exposure in the workplace 
environment.(TMA dust concentration in this area was 3*5 mg/m^.) 
His response to this is shown in the graph below. He developed 
rhinitis and conjunctivitis 5 minutes after onset of exposure 
and complained of chest tightness and dyspnea shortly thereafter. 
Physical examination revealed conjunctival erythema, rhinorrea 
and marked . e:-:p ira tory wheezes throughout both lung fields 
which had not been present on physical examination before 
entering the wharehouse. This exposure was not followed by 
the return of asthma later in the day.
Immunological studies were subsequently undertaken using 
Trimellitic anhydride human serum albumin conjugate (TMA-HSA)
He reacted to this conjugate on skin testing and had 956mg/ml 
total IgE . Specific IgE and IgG levels were determined by
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FIGURE 10 (continued)
CASE HISTORY OF PATIEITr WITH APPAREIL RESPIRATORY ALLERGY
TO TRIMELLITIC ANHYDRIDE (TI4A)
polystyrene tube radioimmunoassay and found to be 11200 cpm 
and 10805 cpm respectively above control levels.
Ui
_J 120
100
80 -
Ui
T M A  
E X P O S  URE
u.
SOPROTERENOL  
1 N HA LA T i ON
20
10 50 6 020 30
M I N U T E S
4 0
Changes in FVC (o-o) and FEV^ (e-e)
Serum from the patient was able to transfer immediate hyper­
sensitivity to the skin of the rhesus monkey.
Peripheral blood leucocyte histamine release was determined 
by incubating cells with the conjugate for 50 minutes, assaying 
the cell and supernatant histamine and calculating the percentage 
release. This was found to be 66^ with 2 ng of TMA-HSA.
lymphocytes from the patient were stimulated with varying 
concentrations of TMA-HSA. Stimulation indices of tritiated 
thymidine incorporation were calculated by dividing the mean 
cpm of the stimulated cultures by the mean cpm of the
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FIGIJHB 10 (continued)
CASE HISTORY OF PATISliT WITH APPARENT BBSPIRATORY ALLERGY
TO TRIMELLITIC AITODRIDE (TMA)
unstimulated cultures. The results are shown in the graph 
below. A stimulation index of greater than 2 was considered 
significant.
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I^^mphocyte reactivity in patient (x-x) , two other workers 
(o-o) & (•-•). Two control subjects have stimulation indices 
of less than 2 (o-a) & (m-«).
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The immediate response is manifested by shortness of 
breath, wheezing and coughing occuring shortly after exposure 
this is followed several hours later by chills, malaise, 
chest tightness and dyspnea typical of the late reaction.
Trimellitic anhydride has given rise to immediate asthmatic 
reactions in some workers. A late reaction with symptoms 
resembling extrinsic allergic alveolitis is also recognised 
and a third response consisting of cough, (which may 
involve coughing up of blood) dyspnea with pulmonary 
infiltrates, a restrictive respiratory defect, hypoxaemia 
and anaemia (referred to as pulmonary-disease-anaemia
311-313
syndrome) has been reported. Immediate type asthma to 
pyromellitic dianhydride in exposed workers has also been
148
found.
These anhydrides all have related chemical structures 
(table 5a) and consequently it is likely that the underlying 
mechanism responsible for the allergic reactions observed 
is similar.
5.3 Antigenic determinant
Anhydrides at*e reactive chemicalsand readily form an amide 
or an imide linkage with amino groups of proteins. (See 
figure 7). It appears that the anhydride inhaled by exposed 
persons reacts with proteins in the respiratory tract 
(possibly in the respiratory secretion) to form conjugates 
which act as allergens. Sufficient quantities of the conjugate 
formed pass into the tissue spaces and blood stream and
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corne into contact with the cells of the immune system 
thereby initiating a response.
3 8 9
Studies on trimellitic anhydride (TMA) using human serum 
albumin and ovalbumin as carriers indicated that the 
likely antigenic determinant includes a portion of the 
protein as well as the trimellitic moiety. However, since 
both TMA conjugates reacted equally well with antibody it 
must be concluded that the part of the protein involved is 
quite small, possibly only 1 amino acid residue, which is 
common to both these proteins. Human serum albumin is a 
respiratory protein ovalbumin is not - consequently 
several other proteins in the body may also be able to act 
as carriers for the hapten.
It has been suggested that as many as 30 trimellitic 
anhydride residues may be attached to the human serum 
albumin molecule but whether 30 separate active sites are 
formed or only one is not clear. Probably 30 amino acid 
residues are available for combining with the trimellitic 
anhydride but only a few of these actually constitute 
active sites. Furthermore the sodium salt of TMA did not
3 8 9
completely inhibit IgG antibody to TMA.
However, immunologic studies on workers exposed to both 
trimellitic anhydride and phthalic anhydride have shown that 
the antibody responses elicited indicated little cross-:/ 
reaction between the antibody directed against 
TMA-HSA or PA-HSA. This would infer that the -COOH group
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FIGURE 11.
POSSIBLE STRUCTURES OF CONJUGATES V/HICH WOULD BE FORMED BY 
THE REACTION OF PHTHALIC AUUYDRIDE V.riTH THE EPSILON AIÎINO 
GROUP OF LYSINE IN A PROTEIN MOLECULE.
1. m i D E  LINKAGE
c= o
NH
NCH^CH^CH^CH-CH
c=o
NH
U  ^  J
phthalic anhydride - lysine moiety
2. AI^IIDE L n m i G E
c=o
?
C-N-CHg CHpWgCH-CH
6=0
NH
COOH I
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of TMA is a key part of the antigenic determinant. It is 
also possible that this group reacts in vivo with other 
protein side chain groups to form a totally unrelated 
conjugate.
X
5.4 Reaction mechanisms
It seems likely from the clinical symptoms observed that 
both a type I and a type III reaction are involved in 
anhydride allergy although both may not be present in 
individual cases. Although immunological tests have not 
been undertaken in all reported cases the evidence obtained
from those which have would seem to support this view. The
probably involves 
initial reaction - loE antibody and the late one IgG.
Indeed TMA-protein conjugates neutralised both types of
antibody.
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Lymphocyte transformation has been reported in some cases 
of apparent phthalic anhydride sensitisation inferring a 
cell mediated mechanism may also be involved. Whilst this 
has not been shown by other investigators studying respiratory 
sensitisation to anhydrides, cell-mediated (delayed) 
hypersensitivity is generally accepted as the causal 
mechanism for allergic contact eczema (dermatitis) and 
it is likely that workers developing dermatitis to anhydrides 
respond via this route.
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Maccia et al demonstrated positive scratch tests in patients 
with respiratory sensitisation to phthalic anhydride after
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application of both PA crystals and PA ethanol solution. 
Patch testing however gave negative results.
It is possible therefore thet phthalic anhydride (and 
indeed other anhydrides) readily react with proteins in
respiratory secretions or in the subdermal tissue
the production of 
to form conjugates which act as antigens fory humoral
antibodies of both IgE and IgG classes ; by locally
circulating plasma cells. On the other hand, phthalic
anhydride directly in contact with skin as experienced
occupationally (or in patch testing) is likely to be in
contact with different proteins and macromolecules and
therefore to form a different type of conjugate. Such
conjugates may penetrate the various skin layers in a
different way (and possibly at a different rate) acting as
an antigen which stimulates cellular antibody production
thereby invoking a delayed type hypersensitivity response.
3 9 4 : 3 9 5
Recent studies have implicated the Langerhans cell as 
*an allergen trap* which absorbs haptens as they traverse 
the epidermis and converts them to complete antigens. 
Furthermore the close association between Langerhans and 
mononuclear cells in allergic contact dermatitis reactions 
suggests that they are involved in transferring antigen
3 9 6
recognition to T lymphocytes.
The reasons why an immediate respiratory reaction is 
invoked in some sensitised workers in contrast to a late
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or dual response in others is not understood. Clearly the 
concentration of the agent, its physical form and the 
duration of exposure will be involved.
Most inhalant allergens in fact do not give rise to contact 
sensitivity. When they are injected they give rise to an 
immediate wheal and flare response which may be followed 
by a late reaction but not by a true delayed hypersensitivity 
reaction. The immediate response may remove all the 
effective antigen therèby/iot allowing a delayed response
3 9 7
to be initiated. Evidence from animal studies has shown 
that immediate allergens injected with an antihistamine 
will give rise to delayed responses.
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CONCLUSIONS AND RECOMMENDATIONS
6.1 Summary of Current Lata
Reactive organic chemicals of low molecular weight 
capable of covalent bonding to groups on amino acid 
side chains of proteins present in the skin layers or 
in the respiratory tract are likely to give rise to 
allergic reactions in susceptible persons who are exposed 
to them.
The susceptible individual will become sensitised to 
the chemical at some stage during exposure but is unlikely 
to manifest any adverse symptoms at the time. Once 
sensitised the individual concerned will produce an 
allergic response to subsequent encounters with the 
chemical even at fairly low concentrations. A response 
is likely to be produced even if the method of presentation 
of the chemical in subsequent encounters is different from 
that initially.
V .
The physical and chemical properties of the invading 
agent (and its constituents) will influence its site of 
entry to the body and therefore the likely proteins 
encountered with which conjugation may occur. Local 
metabolism of the chemical may occur, modifying its 
structure and therefore its protein binding ability.
The permeability and mobility generally of the hapten 
and the conjugate will influence whether only a localised 
response is triggered or circulating cells and antibodies
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are encountered and a more generalised response invoked. 
Reactions involving cell mediated immunity in preference 
to those concerning humoral antibody are only likely to 
occur if the agent is encountered via the general skin 
layer rather than via the respiratory or gastrointestinal 
tracts. However, in certain circumstances both mechanisms 
may be involved.
The production of allergic contact dermatitis (generally 
cell mediated) rather than allergic asthma (humoral 
antibody mediated) : / when certain haptens are
introduced to th° hands as opposed to the respiratory 
tract highlights one of the fundamental points in - 
occupational allergy. This key difference in reaction 
mechanisms is likely to stem from the differences in 
conjugates formed and the antigenic determinants produced. 
The accessibility of conjugates to circulating memory 
lymphocytes of the T and B classes is also likely to 
be of fundamental importance .
The antigenic determinant stimulating specific antibpdy 
production is likely to encompass parts of «both the 
invading haptenic chemical and the carrier protein with 
which it is conjugated and need not be protein specific.
In the case of antibody mediated reactions both IgE and 
IgG are likely to be involved. The response produced and
104
the clinical symptoms observed will depend on the 
secondary mechanisms triggered by them whether complement 
is involved and on what other mediators or factors are 
released from co-operating leucocytes. IgE is associated 
with immediate (type I) reactions with IgG involved in the 
late (type III) reaction. Whilst these two reactions 
commonly occur together only one may be present in 
individual cases.
Irritant, pharmacological and possibly toxic effects of 
chemicals may swamp allergic responses in persons exposed 
to relatively high doses of agents to which they are 
sensitised. Even at fairly low concentrations the observed 
effects may not be entirely due to allergic mechanisms.
6.2 Sensitisation
Despite the advances in immunology and allergy over the 
past decades a full understanding of the mechanism of 
allergy has yet to be achieved. Several key questions 
require to be answered, the following two in particular
1. V/hat predisposes a particular individual
to become sensitised compared to
others exposed to given potential allergens?
2. Once an individual is sensitised what 
control mechanisms operate to activate
a particular response and symptoms rather 
thaman alternative response which may be 
displayed by another individual in 
similar circumstances?
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The reasons why certain individuals are susceptible to 
sensitisation to particular allergens is clearly inter­
linked with the biological role of allergy generally.
Many studies have been undertaken to establish the
3 9 9
reasons why allergy has developed. Current evidence suggests 
that inhalant allergy in particular is a consequence of 
a genetically determined ’increased’ level of local 
immunity.
Mast cells/basophils and IgE antibodies appear to provide 
a good defence mechanism against parasitic worms and this 
may have been an important reason for development of the 
response. In historical and evolutionary terms this 
advantage may have outweighed any possible disadvantage 
from inhalant allergies as currently experienced.
3 9 9
There is also evidence, albeit inconclusive, to suggest 
that cancer patients (particularly those with tumours 
of mucosal surfaces) have a lower incidence of allergy.
Such findings are consistent with the hypothesis that 
atopy is a consequence of a high level of mucosal immunity.
In the general population there are several different 
types of persons who do not experience^allergic symptoms 
to a range of antigens
i) Those who have not been exposed to
a particular allergen,
ii) Those who have been exposed, do not
show symptoms or detectable signs at present 
and who never have had or never will do so.
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iii) Those who are going to develop symptoms
in the future, 
iv) Those who have had allergic symptoms
in the past but who have been 
’spontaneously' cured, 
v) Those who have positive skin tests
and detectable serum IgE antibody but 
deny any symptoms.
All these groups are often referred to as non-allergic 
and may be used in control studies when comparisons 
with allergic patients are made, although clearly they 
are not all necessarily non-sensitised persons. In 
cases of occupational allergy it is fairly easy to determine 
whether a given worker has been exposed to a particular 
allergen and therefore any asymptomatic exposed workers 
will fall into one of the categories ii), iii), iv) or v) 
above.
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Current evidence suggests that delayed sensitisation and 
spontaneous cure appear to be antigen specific; that changes 
in the level of IgG and IgE antibodies generally occur in 
parallel and that spontaneous cure is not directly age 
related. Whether the length of allergic responses are in 
some way related to antigen dose is not known and clearly 
invites further study. A cellular mechanism for spontaneous 
cure and perhaps delayed sensitisation may operate 
involving suppressor T-cells switching off (or on) antibody 
response to a particular antigen.
Clearly the only truly non sensitised group will be those
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falling into category ii) ie, exposed persons who are just, 
non-responders. Further studies involving these persons 
in any study of exposed workers is essential if the 
phenomenon of sensitisation is to he elucidated.
6,5 Control Measures
The rapid development of technology currently occurring
with an ever increasing demand for new products, particularly
Plastics
in they field, is undoubtedly provoking the widespread 
use of chemicals previously of little importance,and the 
continued synthesis of new chemicals. Since a significant 
proportion of these chemicals could be allergens such 
activities are likely to expose many workers to the risk 
of developing sensitisation, unless appropriate safeguards 
are taken. Prevention rather than treatment must remain 
the objective in dealing with occupational allergy, on the 
one hand by reducing contact with potentially harmful 
agents and on the other by selection and monitoring of 
those employed. Prediction of likely sensitisers before 
use is also important.
A summary of important control measures is given in 
Table 11. These methods are not mutually exclusive, the 
greatest benefit will be derived where several are used 
together.
Ideally substitution of known or suspected sensitisers 
with ’safer’ alternatives is the best practice. However, 
for many important industrial chemicals there is no 
satisfactory alternative for the product available.
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TABLE 11 ; CONTROL MEASURES
1. SUBSTITUTION
- OP THE PARTICULAR SUBSTANCE
- OF THE PROCESS INVOLVED
2. ISOLATION (of the chemical from the worker)
>  BY ENCLOSURE
- BY DISTAiqCE
- BY TIME
5. VENTILATION (of the working environment)
- GENERALLY BY DILUTION
- LOCAL EXHAUST SYSTEMS
4. PERSONAL PROTECTIVE EQUIPMENT
- GLOVES, OVERALLS, FOOTWEAR
- RESPIRATORY EQUIPMENT, MASKS
5. GOOD HOUSEKEEPING
- PREVEITTION OF SPILLAGES, ACCUMULATIONS
- ROUTINE MAINTENANCE AND TESTING OF PLAITT
6. TRAINING AND EDUCATION OF WORKERS
- ON PREVENTATIVE MEASURES, HAZARDS INVOLVED, 
GOOD PRACTICES .
- REPORTING OF PROBLEMS, SYMPTOMS
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Furthermore questions of toxicity, flammability and explosion 
hazards will clearly outweigh sensitisation potential 
when particular chemicals are considered. Of course the 
likelihood that a given chemical will give rise to sensitisation 
in exposed workers cannot be clearly predicted although 
obviously certain indications can be derived from animal 
studies and pre-screening of atopic subjects. \Jhen a 
particular chemical is found to be a significant sensitiser 
steps must be taken at that stage to consider whether it 
can be substituted before the problem develops further.
Wherever possible workers should be divorced from problem 
chemicals. In many cases reaction vessels, moulding machines 
etc. can be totally enclosed such that workers operating 
the process or the machine in question are isolated 
from the substances involved. Where enclosure is not total 
the greater the distance between the worker ând the plant 
the better and the location of operating controls should 
reflect this. Isolation can also be achieved where workers 
do not enter hazardous areas until chemical reactions have 
been completed and thus the concentrations, temperatures 
etc. of particular chemicals will have been reduced.
Unfortunately whilst isolation of production workers can 
often be achieved other groups particularly maintenance, 
cleaning and inspection staff, by the very nature of their 
work, have to gain access to problem areas thereby requiring 
other control measures.
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Airborne concentrations of harmful agents at the workplace 
can be reduced in most cases by efficient environmental 
control of dust and vapour. A suitable efficient and 
properly maintained extract ventilation of the workplace 
or more particularly as a local exhaust system, is an 
essential prerequisite. The use of personal protective 
equipment ranging from filter-type face masks (which are 
often inefficient, uncomfortable and not tolerated by 
workers) to positive pressure air hoods and full breathing 
apparatus will prevent (to varying degrees) inhalation of 
contaminated factory air. The wearing of appropriate 
gloves, overalls and boots is also important. Even the
401
use of barrier creams is significant. Complete isolation 
of workers from the substance in question with handling 
and observation through the wearing of special containment
402
suits may have to be used in certain cases, a practice 
well established where bio-hazards are concerned and in 
the nuclear industry.
Routine on-going monitoring of the workplace checking 
dust levels, particulate sizes, gaseous concentrations 
and related factors is vital to ensure that ventilation 
system provided is working satisfactorily and that other 
control measures are adequate. Such monitoring must 
clearly reflect the type of work undertaken and identify 
potential ’hot spots’ in the workplace rather than merely
403:404
establishing an average ambient level.
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Defining a suitable reference level however, is virtually 
impossible and attempts must be made to obtain as low a 
concentration of the chemical as possible, preferably at 
a limit of the ordeir of, or below that which can be detected 
by mo d e m  instrumentation. The introduction of Control 
Limits, Long Term Exposure Limits (LTEL^Short Term Exposure 
Limit (STEL) and other measures of 'safe’ levels for 
particular chemicals has been an important step forward 
in controlling and restricting exposure to hazardous 
chemicals. However, such levels are principally designed 
to avoid workers developing acute or chronic conditions 
(eg. asphyxia, cancer) rather than in preventing sensitisation 
for which there is practically no safe level in susceptible 
individuals.
The principal basis for the determination of these limits 
is toxicity testing of the chemicals of animals and whilst 
this provides a background of information concerning 
potential acute and chronic effects on man, in the case 
of sensitisation and allergic response there are no 
established animal tests to screen for the existance of 
sensitising effect on humans. Even if sensitisation can 
be shown in particular animals there is no guide to 
its effect in man, indeed the reasons for one individual 
human being more susceptible to sensitisation than 
another are not understood. Structure and reactivity 
of given chemicals provide useful pointers as indicated 
in this study and more attention could beneficially be given 
to such matters.
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However, in many industries the exact nature of the chemicals 
involved is often not known and cannot readily be predicted 
prior to the process starting.
Prevention of exposure must not be confined to the shop 
floor or stop at the factory gate. Any control measures 
adopted to protect front line workers must not give 
rise to hazards to other groups of persons (including 
the general public). The proper treatment and discharge 
of extract ventilation systems, the correct laundering 
of contaminated protective clothing, the safe disposal of 
both solid and liquid wastes and monitoring of the 
external environment are equally important. Cases of 
individuals not actively working with particular substances 
yet suffering allergic symptoms are not uncommon, and can 
often be traced to unsatisfactory conditions in these 
areas.
Transfer of potential allergens to workers clothes and 
the introduction of such agents into.the home and other 
non-work environments can also pose serious problems.
Exposure of the workers themselves is increased theretgr 
prolonging the suffering of sensitised individuals beyond 
the working day. The likelihood of sensitisation developing 
in non-sensitised workers is increased and, more 
importantly, exposure of the worker's family to potential 
sensitisation and subsequent allergy can occur in such 
situations.
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Comprehensive & cotinuing education and training of 
workers together with a high standard of occupational 
hygiene is essential to eliminate this. The problem 
is more ‘difficult in non-industrial situations where 
washing and changing facilities may not be readily 
available and indeed where the exposed employees may 
actually work from home (eg. in forestry and farming.)
It is imperative that the established attitudes, prevalent 
in some industries, that suffering is part of the job 
must be discarded.
6.4 Screening of Workers
Pre-screening of workers for susceptibility to sensitisation
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is clearly a desirable measure. Unfortunately this is 
not as simple or advantageous as it might appear. The 
obtaining of médical questionaires and patch testing 
using a specific batch of chemicals are established ways 
of identifying whether workers are atopic. Such procedures 
are often undertaken when workers are liable to be 
exposed to dermatitis problems. However, it appears that 
although an individual may be atopic he is not necessarily 
any more susceptible tp respiratory sensitisation by a 
given agent than a non-atopic worker. Indeed non-atopic 
workers are often more susceptible. Furthermore 
susceptibility to sensitisation to a given agent does 
not automatically imply susceptibility to sensitisation 
by other agents.A greater understanding of the reasons 
why individuals are susceptible and the molecular basis 
of sensitisation are clearly important if predicting 
susceptibility and screening of workers is to be successful.
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Notwithstanding these problems the routine monitoring 
of exposed workers is an important function to ensure 
signs and symptoms of sensitisation in individuals are 
identified at the earliest opportunity in order that 
steps can be taken to alleviate the individual’s condition 
and improvements in the control measures operating can
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be instituted. The organisation and establishment of 
multidisciplinary Occupational health services at work­
places are clearly fundamental to achieve this task and 
it is encouraging that many organisations now possess such 
units. Part time external medical advisers and consultants 
have a role to play but can never operate with the same 
effectiveness or provide the same expertise and commitment 
as an integral occupational health service.
By the time a patient presents with occupationally induced 
respiratory symptoms preventative measures have failed.
It is also obvious that the most effective form of treatment 
is to remove the worker from the hazardous environment, 
or at least to relocate him in another part of the plant.
In this instance social, financial and other implications 
must all be considered. Very often suitable alternative 
employment in areas away from the substance cannot be 
offered or the worker may refuse jobs for which he is 
unsuited or which carry lower pay. Premature retirement 
or dismissal on health grounds may be the only practical 
alternatives. In certain circumstances sensitised workers 
may continue to work, and remain exposed to the allergen
115
concerned whilst undergoing some prophylactic treatment 
such as taking disodium cromoglycate. Clearly this latter 
course of action should not be taken lightly and may 
involve the worker in additional problems in the long 
term. (eg.asthma originally caused by sensitisation to 
a particular agent may develop into a non-specific 
form such that the sufferer experiences symptoms even 
when no longer exposed to the original agent.)
As indicated previously, a speedy correct diagnosis of
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the worker’s complaint is essential. It must involve a review 
of the patient’s past medical history, checking current 
activities (at work and elsewhere), and thorough medical 
examination and where possible bronchial challenge with 
suspected agents, skin testing and laboratory immunological 
studies. Cases where individuals initially suspected 
of being sensitised to a particular compound in the work 
situation subsequently, following more extensive investigation, 
being diagnosed as allergic to a totally unrelated 
substance are not uncommon. Once a single case of sensitisation 
to a given agent has been established in a particular 
workplace,it is more imperative than before to ensure 
routine monitoring of the working environment is 
undertaken, that control measures are correctly operating 
(and where possible to extend them) and more importantly 
that regular medical screening and examination of exposed 
workers continues with the aim of identifying additional 
cases of sensitisation at the earliest stages.
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6.5 Availability of Information
A large proportion of the published literature and current 
data is of little practical use in assessing the aetiology 
and pathogenesis of occupational allergy since basic 
immunological studies have not been undertaken in many 
cases. Provocation tests, determination of total and 
specific IgE antibody levels and similar studies are key 
operations which should and must be undertaken if unequivocal 
diagnosis of allergy is to be made and the causal agent 
clearly established. The continuing doubts and conflicting 
data in respect of an allergic mechanism for isocyanate 
asthma clearly illustrates this point. Whilst the immediate 
diagnosis of the patient’s condition and its treatment must 
remain of prime concern this should not conflict with the 
wider objectives of obtaining all possible data relative 
to sensitisation to a given agent. Indeed the two tasks 
are mutually beneficial.
There is clearly a need for more liaison and interaction 
between the various disciplines and professions involved. 
Physicians intimately involved with the patients under 
their care often have little scope, inclination or 
opportunity to discuss individual problems with safety 
officers, engineers and factory management. Furthermore 
differences in emphasis, priorities and specialised 
knowledge amongst physicians can inhibit factory medical 
advisers, general practitioners, local hospital consultants 
and research academics from pooling resources and exchanging
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ideas not only on individual problems but on the subject 
generally. Ultimately university and other research 
workers concentrating on immunological methods or animal 
studies are likely to become detached from the problems 
of industry and exposed workers.
Whilst the establishment of local occupational health 
services by many major employers is clearly an important 
development more special project teams and interdisciplinary 
research groups are essential if the full benefits of 
current knowledge and awareness are to be utilised in 
achieving good safe healthy working conditions. Bodies 
such as the Health and Safety Executive, the Employment 
Medical Advice Sezrvice, occupational health institutes as 
well as both employers and trades union organisations 
have important roles to play and must resolve their 
parochial, political and ideological differences if they 
are to be fully effective.
Obviously confidentiality on behalf of the patient (and 
his medical adviser) as well as the employer concerned 
is important not only in relation to legal and financial 
matters but also with regard to current public awareness 
and marketing cmsiderations. Nevertheless such considerations 
must not inhibit the constructive beneficial dissemination 
of information which is so important in order to protect 
others.
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Clearly all employers have both moral and legal duties 
to ensure that not only their workers but all persons 
likely to be affected by their business undertakings 
are safeguarded. Residents living in the immediate 
vicinity of industrial plants and the end users of 
particular products (including the general public) may 
all be unwittingly involved. Close liaison between factory 
operators and residents associations and also between 
manufacturers and consumer marketing organisations 
on such health matters is essential.
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APPmDIX I
TESTS USED IN ALLERGY INVESTIGATIONS
SKIN TESTS
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The two basic skin tests are the patch test (used
principally for dermatitis investigation) and the prick 
test (used principally for asthma and rhinitis).
In the prick test a drop of reagent is placed on a clean 
dry healthy area of skin (the forearm is a convenient 
site) and a sharp needle is passed through it at a 
shallow angle superficially in the skin giving a slight 
lift to the skin, withdrawing the needle in a direction 
at right angles to the skin to produce a perceptible 
'plink*. The reagent is blotted with a disposable tissue.
It is estimated that approximately three ten-millionths 
of a ml. are introduced into the dermis by this technique. 
Reading takes place ten to twenty minutes later for 
maximal effect but delayed reactions may occur from 2 to 
72 hours later.
A positive reading is a wheal 1mm or greater in diameter.
There may be itching, a red flare and pseudopodial 
development, (indicative of a Type I, immediate reaction.)
The immediate response may run into a secondary oedematus 
reaction often strikingly raised above the surrounding skin and 
extensive, obvious after three to four hours and maximal 
after seven to eight hours. It is itchy and its borders 
are ill-defined, (indicative of a Typelll, Arthus reaction.)
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At forty-eight to seventy-two hours after the secondary 
reaction has subsided, a.third may occur that is 
erythematous and indurated, (indicative of a Type IV, 
delayed reaction.)
The technique of patch testing is simply the application
of the test material, in solution or solid on a piece
2of lint or linen 1cm , to the skin - usually the back but 
sometimes the arm is used.
The patch test reactions are read at 49 hours after 
application although reactions may be positive earlier 
in cases of marked sensitivity. The reactions are graded 
from 0 to 4+
0 no reaction
1+ erythema
2+ erythema, papules
5+ erythema, papules and vesicles
4+ marked oedema and vesicles.
Low grade reactions (O to 1 or 2+) are probably not 
significant. A second reading is usually made ninety-six 
hours after application. Patch testing can be altered 
by the topical use of corticosteroids and systemic 
corticosteroid therapy may suppress most reactions thereby 
significantly affecting the results.
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PROVOCATION TESTS
Whilst oral and nasal provocation tests are used in 
allergy investigations it is bronchial provocation 
testing which is a fundamental tool in occupational 
allergy and has been used extensively in the investigation 
of patients with asthma and extrinsic allergic alveolitis 
since 1947•
Bronchial provocation testing is routinely used to 
evaluate dusts, gases, vapours, and fumes suspected of 
causing occupational asthma and is also a useful method 
to monitor the effects of immunotherapy or the effectiveness 
of drugs. However, although a particular drug may alleviate 
bronchial response to allergen on provocation testing it 
may not be effective clinically. Provocation testing is 
normally undertaken in hospitals where remedial facilities 
and appropriate treatment are available should they prove 
necessary, although these tests are normally considered 
safe.
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The principle method used simulates work exposure to the 
particular agent and is carried out in an exposure chamber 
with adequate extraction facilities.
The allergen concerned may be presented in various ways 
dependant on its physical properties. For example grain 
and wood dust are best tested by the patient tipping
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materials from one container to another whilst vapours 
from soldering fluxes are readily tested by the subject 
actually performing the soldering process.
Unfortunately with this test it is difficult to assess 
the dose of material inhaled by the patient. For many 
materials in the chamber, however, the concentration 
can be measured by air sampling and chemical analysis.
V/here possible the challenge concentration should reflect 
the known or suspected concentration encountered in the 
work environment. If the initial test proves negative it 
is repeated with concentrations 2 to 5 times greater 
(generally tests repeated at 10 min intervals) until 
result obtained. Duration of test - 15 to 30 minutes.
Respiratory function is measured 50 minutes and immediately 
before the bronchial provocation test and then every 5 minutes 
after the test for 1 hour and subsequently hourly for the 
rest of the day. It is essential that the tests commence 
early in the day so that sufficient observations can be 
made to detect the presence of a late reaction should one 
occur. Where a late reaction or extrinsic allergic 
alveolitis is likely to occur (predicted from case histories 
of the patient etc.) only 1 test per day is undertaken on 
subsequent days.
It is essential that all forms of medication which the patient 
may have been receiving are withheld for a period prior to 
bronchial provocation testing.
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An alternative method for the test involves nebulised 
extracts of the allergen or pharmocological agent being 
inhaled by the subject through a special form of 
breathing apparâtus. However, this bears little resemblance 
to natural exposure especially to those agents which 
normally occur in particle form and furthermore the dose, 
rate of exposure (rate of administration), presentation 
of allergen or the site of deposition within the respiratory 
tract is unlikely to be typical of occupational exposure.
A method of bronchial provocation testing using soluble
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antigens has been developed by Harries et al.
The test material is inhaled as an aerosol from a Wrist’s 
nebuliser through a tight fitting face mask with an oxygen 
flow rate of 8 litres/minute. Respiratory function is measured 
every 5 minutes for 20 minutes before the test; every 10 
minutes for 50 minutes after the test then hourly for the next 
12 hours. A positive inhalation test is registered when a fall 
in EE7. of 13% or more (compared to the control day) occurs 
within 24 hours of the test or where a rise in temperature, 
malaise, leucocytoses, development of crackles in the lungs 
or a fall in transfer factor of 159^  or more (compared to 
control day) occurs within 24 hours of the test.
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RESPIRATORY FUNCTION TESTS
These involve the measurement of various lung volumes 
and generally involve comparisons of the results-obtained 
in healthy subjects with those in patients exhibiting 
respiratory symptoms especially in asthma.
The tests are carried out using various forms of recording 
spirometers. One of the commonest of these is the vitalograph, 
an instrument which measures the volume of gas expired 
during the period of exhalation (at ambient temperature 
and pressure) and records this against time on a chart.
(See figure 12) The subject sits breathing into the apparatus 
by mouth with his nose sealed. He then takes a maximal 
inspiration and immediately breathes out forcefully, 
rapidly and completely as possible into the vitalograph.
The maximal volume of air that can be expelled in one
second is called the Forced Expiratory Volume (FEV^). This
reflects the resistance offered by the airways (bronchioles,
bronchi, trachea) to the expired air. The total volume
expelled is the Vital Capacity (VC). These two records
are normally expressed as a percentage ie. FEV
VC
In normal cases this figure is approximately 80^ but it 
is decreased in patients with airways obstruction.
Vital Capacity is related to the size and development of
2 2 the subject.(Usually 2.6l/m in males and 2.1 l/m in females.)
It is decreased in older people and in those suffering from
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FIGURE 12.
RESPIRATORY FUNCTION TESTS (AU EX/iHPLE OF A VITALOGRAPH
RECORDING)
FEV.
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certain respiratory diseases eg. polio, respiratory 
obstruction, pleural effusion, pneumothorax, pulmonary 
fibrosis, emphysema and pulmonary oedema.
Several other lung volumes and capacities (See figure 13) . 
can also be determined by simple spirometry. The basic 
recording spirometer consists of a counter-balanced, 
inverted cylinder moving vertically inside a water-filled 
bhamber so that a variable colume of air or gas is trapped 
under the cylinder. The cylinder is connected to a recording 
drum (Kymograph) such that when the lung volume increases 
in inspiration, the volume of the gas in the spirometer 
is reduced and the pen on the chart rises; conversely the 
pen falls with expiration.
The subject breathes through the mouthpiece in a closed 
circuit with the spirometer and his nose sealed. The 
instrument records the volume of air movement against 
time and a record of normal breathing and of deep inspiration 
and full expiration is made. The following lung volumes 
can then be calculated:-
a) Tidal Volume (V^) - the amount of gas inspired 
or expired during a single normal breath
b) Inspiratory Reserve Volume (IRV) - maximal 
amount of gas that can be inspired after a normal 
inspiration
c) Inspiratory Capacity (IC)=IRV + V^
d) Expiratory Reserve Volume (ERV) - maximal
amount of gas expired from the end-expiratory position
e) Vital Capacity (VC) = IC + ERV
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FIGURE 13.
LUNG VOLUMES AND CAPACITIES
A representation of a recording obtained by a spirometer 
to illustrate the sub-divisions of the lung volume# The 
figures on the left are the average values for an adult man.
H-
O
ww
_ O  I
^  >  I' ë I
' £ !
'â j
>- I
tr Io  I
wo >w K-
CJ
w
w
> -cn
w
t/3
wcc
cn _j 
w  o  
cc >
o
cc
I cn CL
X
w
VITAL CAPACITY
cc >- 
a  h-
O  CD H-t
W  o  U<r cj 
cc ex 
w  O. 
CL cc
cn CJ
CJ cn CL 
z  w  < 
ZD cc CJ
w
CJ 
L3 >
cn Q
W  H-i
cc H
TOTAL LUNG CAPACITY
cn
w
cc a\ CD
in to
128
Measurements of Residual Volume (RV), Functional Residual 
Capacity (FRO) and the Total Lung Capacity (TLC) have tb 
he determined by a separate technique - the closed 
circuit helium dilution method is often used. Residual 
volume may however be calculated using the following 
arbitary formulae
Males RV (ml) = 26 x age (years) + height (inches) 
- 11 X weight (pounds) - 4570 
Females RV (ml) = 10 x age + 1520 
Hence FRO = ERV + RV and TLC = VC + RV
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LABORATORY TESTS
Determination of total serum IgE, a routine clinical 
procedure, is normally undertaken by a form of Radio­
immunoassay (eg.) the Double antibody inhibition radio­
immunoassay or the Radioimmunosorbent technique (RIST). These 
tests which are fairly sensitive involve antibody- 
antigen interaction in which one of the reactants has been 
labelled with an appropriate radioactive isotope. The 
key step involves competition between labelled and 
unlabelled forms of one reactant (in this case IgE) for 
binding sites on the other reactant (anti IgE). The 
labelled antigen is usually present in slight excess 
over the antibody. Since the capacity of antibody to bind 
antigen is limited addition of serum containing unlabelled 
antigen will cause a decrease in the amount of labelled 
antigen that is bound.
In the double antibody inhibition RIA the test serum is 
mixed with rabbit anti-IgE and the radiolabelled IgE added. 
Goat anti-rabbit is then added to precipitate the rabbit 
immunoglobulin and after washing the radioactivity in 
the precipitate is counted.
The RIST uses a solid phase for one of the reactants 
therefore a second antibody is not required. Particles 
of activated cellulose or similar material are used to 
bind anti-IgE preparation. The mixture is then centrifuged, 
washed and the radioactivity on the immunosorbent counted.
The amount of label bound to the insolubilised antibody 
is therefore inversley proportional to the amount of IgE
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in the test serum.
The quantity of IgE present in the test serum can then 
he found by reference to a ’standard curve’ (ie.) a 
graph showing the percentage of labelled IgE bound as 
a function of the amount of unlabelled IgE present. The 
curve having been constructed from data obtained by 
performing the assay using samples of unlabelled serum 
in which the concentration of IgE present is known.
The Badioallergosorbent TestfR.A.S T.)
The level of antigen-specific IgE can be determined by 
this method. Specific allergen is coupled with an insoluble 
matrix (eg. cellulose beads) and the particles allowed to 
react with the test serum. IgE antibody with specificity 
for the coupled antigen will bind to the particles. A 
further incubation is performed by adding radiolabelled 
anti-IgE. The percentage of the added counts bound to 
the matrix is a measure of the antigen-specific IgE in 
the test serum.
EAST correlates quite well with clinical allergy but 
precise correlation with skin tests awaits antigen 
standardisation. Clinical scores are obtained by comparison 
with EAST results with strongly positive reaginic sera:
A 4+ EAST precipitates as much radio-labelled antibody to 
IgE as does a 1:1 dilution of reference sera; a 2+ EAST
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precipitates as much as a 1:4 to 1:25 dilution and a 
negative EAST indicates less reactivity than a 1:50 dilution 
of reference sera. False positive results are rare with 
this technique. Clinically the EAST may provide an 
alternative to skin tests in persons with dermagraphism 
or severe dermatitis, in apprehensive adults or small 
children.
Furthermore the EAST allows a safe diagnostic approach when 
intradermal (eg. bee sting) or provocation tests may be 
hazardous, or when the withdrawal of drugs (eg. anti­
histamines) inconveniences the patient. Another advantage 
is the possibility of being able to study physiological 
fluids other than serum (gut or nasopharangeal secretions 
for example). The fluids could be stored, as could serum, 
for future analysis at a convenient time.
The EAST has been useful in demonstrating IgE antibody 
to such diverse agents as ragweed, grass, pollens, nuts, 
Hymenoptera extracts, insulin and the penicilloyl 
antigens of penicillin.
Eed-cell linked antigen-antiglobulin reaction (ECLAAE)
This technique makes use of red blood cells as indicator 
particles. Eed cells are ideal indicators of antigen- 
antibody interactions because they are less liable to 
adsorb 'proteins non-spec if ically l.: than are other indicators,
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The antigen is first coupled to rabbit antibody directed 
against the red cells (the use of this reagent prevents 
excessive disturbance of the red cell membrane and 
clumping which would occur if the antigen was coupled to 
them direct.) The reagent formed when incubated with the 
indicator cells links to them by means of the antibody 
without damage of the membrane. If the cells coupled to 
the reagent are then incubated with serum containing 
antibody with specificity for the coupled antigen combination 
takes place. Antiglobulin specific for the heavy chains 
of the antibody used is added to agglutinate the red cells. 
(This enables specific antibody of IgE, IgG and other 
immunoglobulin classes to be separately determined.)
Antigen binding radioimmunoassay (or radioimmunoprecipitation) 
A technique which enables IgG, IgA and IgE antibody in a 
given serum sample to be determined in parallel^,. Using low 
concentrations of allergen the relationship between 
different classes of antibody is accurately reflected. 
Furthermore since in vivo exposure to allergens is probably 
at low concentration antibodies measured in the presence 
of low concentrations may reflect the biologically 
relevant antibody.
Serum samples are incubated with radiolabelled allergen 
and carrier protein for 4 hours. Goat anti-IgE (or IgG 
or IgA) is added and left overnight to precipitate then 
the precipitate is washed and the radioactivity counted.
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The count is directly related to the quantity of specific 
immunoglobulin in the serum.
The assay however requires large quantities of IgE 
and IgE myeloma serum (as carrier protein) and so is not 
normally used in preference to EAST for routine IgE 
determination.
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APPENDIX II
GLOSSARY
Al^AEMIA Bloodlesness - in particular shortage of haemoglobin 
in red blood cells characterised by signs and symptoms of 
oxygen lack.
AIsAPSYLAXIS An extreme form of allergy whereby the subject 
reacts very sharply. In severe cases the bronchi go into 
spasm and death may result unless prompt treatment with 
adrenalin is given. Commonly used to mean a type 1 
allergic reaction.
ASTHT'IA A respiratory disease characterised by recurrent 
attacks of difficulty in breathing usually accompanied 
by wheezing, cough and a sense of constriction of the 
chest. It is due to spasm of the muscular fibres in the 
walls of the bronchioles reducing the size of the airway 
and impeding respiratory airflow -especially’ when breathing 
in.
ATOPY The capacity of an individual to develop type 1 
allergy to common environmental materials which is demonst­
rable by skin or serological tests without necessarily 
being linked to the presence of clinical symptoms. It 
appears to be hereditary and involves genetic factors 
but is not fully understood.
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BASOPHIL A type of white blood cell containing granules 
which stain blue/black. They are found in much fewer 
numbers than either neutrophils or eosinophils. Their 
function is poorly understood but they are implicated in 
histamine release in immediate type hypersensitivity - 
analogous to that found with mast cells.
BRAXOlKINIH a  polypeptide that causes the walls of blood 
vessels near the site of an injury to be more permeable 
allowing fluid to escape into the tissues. It is also 
capable of inducing contraction of smooth (involuntary) 
muscles.
CEILIITG LIMIT A term used when defining occupational 
exposure limits, (sometimes referred to as the Threshold 
Limit Value-Ceiling) indicating the concentration that 
should not be exceeded even momentaa^^o :
COIÎTROL LD'IIT The level of an airborne contaminant, 
averaged over a specific time period,above which personal 
exposure is considered to be unacceptable.
DISODIUM CROMOuLYCATE A non-corticosteroid drug which 
inhibits the release of histamine and SRS-A from sensitised 
human lung. It is not antagonist of histamine or SRS-A and 
is not anti-inflammatory. Effective in many patients in 
preventing but not reversing experimentally induced allergic 
or exercise associated asthma.
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DYSPNOEA Undue breathlessness and abnormal awareness of 
the effort of breathing.
EOSINOPHILS White blood cells containing large granules 
readily stained with the red dye eosin which originate, 
from the bone marrow. Increase in the concentration of 
these cells above 4^ of the total white blood cell numbers 
occurs in several conditions including some allergies.
They accumulate at the sites of antigen/antibody reaction 
in response to specific chemotactic factors liberated 
locally, immune reactions involving IgE are particularly 
likely to attract eosinophils. They are implicated in 
processing and cell to cell transfer of antigen breakdown 
products and their phagocytic potential is well documented.
ERYTHEMA Abnormal reddening of the skin. Erythema with 
rise in temperature generally heralds onset of fever whereas 
erythema without rise in temperature is most commonly 
the result of allergy.
HEMOPTYSIS Coughing up of blood from some part of the 
respiratory tract.
INDURATED Hardened or calloused.
LICHENIFICATION An area of thickened and hardened skin 
in which the normal skin markings are visibly accentuated. 
This condition is usually due to chronic inflammation 
resulting from scratching.
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LYMPHOCYTE A type of white blood cell (leucocyte)
involved in adaptive immune responses particularly in the
recognition of antigen and the specificity of all responses
made against it. Small lymphocytes carry the information
for binding to antigen and a vast number of different 
specificities exist in the whole lymphocyte population.
They are capable of several quite distinct activities ranging
from the ability to differentiate into antibody producing
cells to being cells directly involved in cell-
mediated immunity. Two distinct types are found: the so
called Bcells from the bone marrow involved in
antibody production, and the T cells which develop under
the influence of the thymus gland and are involved in
cell mediated immunity. Cooperation between the two
tjpes occurs in several reactions,
LYl'IPHOEINES Chemical substances which affect certain types 
of cell (including macrophages and various white blood 
cells) in a multitude of ways in order to augment a 
particular immune response. Commonly secreted by 
lymphocytes.
MCROPHAGES Large cells circulating in normal individuals, 
capable of carrying out several functions. One of the 
most important of these being phagocytosis - ingestion 
and digestion of foreign material. They contain packets 
of enzymes capable of bringing about proteolysis of such 
material.
M S T  CELLS Cells found in connective tissue filled with 
coarse granules. They secrete heparin (anti-clotting
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agent of blood) and histamine. Release of histamine 
in particular is triggered in type 1 allergic reactions 
by a mechanism not fully understood but which involves 
binding of IgE antibody to receptors on the cell prior 
to antigen/antibody reaction. Histamine release can be 
initiated by other mechanisms involving mechanical or 
chemical irritation.
IÎEÏÏTROPHILS Phagocytic cells present in the blood, more 
motile and effective phagocytes than macrophages. Neutrophils 
form one of the first lines of defence in the body 
being one of the first cells to arrive on the scene in 
large numbers at the site of entry of foreign material 
into the body. They may be attracted towards target 
material by chemotaxis.
OEDEMA Abnormal accumulation of watery fluid in the body 
tissues and cavities.
PAPULE A pimple or small projection raised above the surface 
of the surrounding skin. Hence PAPILLARY.
PHAGOCYTOSIS The process of ingestion and digestion of 
foreign material by certain cells, principally macrophages 
and neutrophils. Phagocytosis occurs throughout the body 
but the liver is a principal site. An important part of 
native immunity as well as in specific reactions of adaptive 
immunity.
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PROPERDIN A protein present in the serum and body fluids 
participating in the complex system of natural immunity. 
Its activities include bactericidal action against gram- 
negative bacteria, neutralisation of some viruses and 
protection against fatal radiation sickness.
PROSTAGLANDINS A series of related fatty acids found in 
various parts of the body and which-act as local hormones. 
They have the ability to lower blood pressure and can 
inhibit the activity of catecholamines in mobilising free 
fatty acids.
PRURITIC Irritant or itchy.
PSORIASIS A fairly common skin disease characterised 
by the formation of red patches which are covered by fine 
silvery scales. Hence PSORIASIFORM.
PURULENT Containing or discharging pus.
RHINITIS The generic term for inflammation of the mucous 
tissue of the nose. \-/hen it is allergic in origin it is 
usually referred to as hay fever. The symptoms are 
sneezing, rhinorrhea, nasal obstruction and itching of the 
nose, palate and pharynx.
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SHORT TERM EXPOSURE LIMIT (STEL) An occupational 
exposure limit aimed primarily at avoiding acute effects 
or at least reducing the risk of occurence. They are 
normally expressed as 10 minute time weighted average (T¥A) 
concentration. The units being parts per million (ppm) 
or milligrams per cubic metre of air (mg/m^). These limits 
are considered to represent good practice and realistic 
criteria for the control of exposure, plant design, 
engineering controls and, if necessary, the selection 
and use of personal protective equipment. STEL and Long 
Term Exposure Limits (LTEL) are listed for a large range 
of materials in a Health & Safety Executive Guidance Note. 
Sensitised individuals may well react to exposure to 
minute levels of substances (acting as allergens) well 
below these listed concentrations.
LONG TERM EXPOSURE LIMIT (LTEL) An occupational exposure 
limit concerned with the total intake over long periods 
intended to protect against the effects of long term 
exposure or reducing the risks to an insignificant level. 
They are normally expressed as 8 hour time weighted average 
concentrations.
URTICARIA An allergic condition characterised by the 
rapid appearance of weals and blisters on the skin 
usually lasting for only a few hours and accompanied 
by intense itching. Thought to be due to release of 
histamine leading to raised vascular permeability and 
local acccumulation of fluid in the dermis of the skin. 
Urticaria may also be produced by non-immune reactions.
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VASODIMTIOH Expansion of a blood vessel.(Reverse referred- 
to as vasoconstriction.)
VESICLES Small blisters occurring as an eruption on the 
skin or mucous membrane conventionally not larger than a 
pea. The h o m y  layer of the skin is raised by exudation 
of clear or turbid fluid to form a rough hemispherical 
protrusion sometimes surrounded by a red inflamed zone. 
Hence VESICULAR.
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